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Abstract 
This doctoral thesis focuses on the development of miniaturized biosensing systems for the 
study of biomolecular interactions. Acoustic biosensor quartz crystal microbalance (QCM), 
partial filling affinity capillary electrophoresis (PF-ACE), and open-tubular capillary 
electrochromatography (OT-CEC) were developed to allow study of interactions between 
glycosaminoglycans and lipoproteins, which are responsible for the accumulation of low 
density lipoprotein (LDL) on the arterial wall.   
The first step was to develop suitable coating methods for the immobilization of selected 
glycosaminoglycans on chip and capillary surfaces and to develop a neutral capillary surface 
for PF-ACE studies. Evaluation of different coating procedures demonstrated the significance 
of the procedure for the successful outcome of biological interaction studies. 
With suitable platforms available for the instrumental techniques in question, studies of 
interactions between glycosaminoglycans and lipoprotein particles were carried out to 
evaluate the strength of the binding processes.  Affinity constants, retention factors, and 
reduced mobilities were measured. Since the commonly used approaches typically allow only 
the strongest binding site of the system to be determined, the scope of the investigation was 
broadened by introducing adsorption energy distribution (AED) calculations in the processing 
of QCM and PF-ACE data. Finally, molecular dynamics (MD) simulations were used as a 
supportive tool to visualize and study interactions at the atomic level. In addition, microscale 
thermophoresis, a relatively new technique, was used to complement and support some of the 
experimental studies.  
The results obtained by QCM methods, PF-ACE, OT-CEC, and MD simulations were in 
good agreement. Even minor changes in the binding process could be visualized by exploiting 
AED calculations in the data processing step. The main advantages of all three experimental 
methods were low sample consumption, relatively fast analysis times, and the possibility to 
evaluate the heterogeneity of the interactions.  
The findings of the work demonstrate the great potential of the developed biosensing 
systems for biomolecular interaction and biomimicking studies. Of particular interest is the 
availability of information on heterogeneous reactions when AED calculations are applied in 
the interpretation of QCM and PF-ACE results. 
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1. Introduction 
Instrumental analytical techniques have become indispensable in the study of biological, 
toxicological, and environmental phenomena and interactions. Nano- and microsystems and 
miniaturized instrumental techniques, enabling studies with minute amounts of samples and 
reagents, undoubtedly will be key technologies for future research in biochemistry, 
biotechnology, and medicine. Small instrument sizes also enable in situ measurements and are 
particularly suitable for the study of biomaterials. New approaches, combining advanced 
chemical, molecular, theoretical, and computational concepts with novel miniaturized 
instrumental techniques, have the potential to provide complementary and even totally new 
information about biological systems and processes. With this in view, my research was 
focused on the development of miniaturized techniques and tools applicable to the 
investigation of biomolecular interactions, specifically interactions relevant to the development 
of atherosclerosis.  
The continuous flow quartz crystal microbalance (QCM) was selected for the further 
development of biosensing systems and to carry out biomolecular interaction studies. 
Capillary electromigration techniques are versatile tools for a diversity of biological 
interaction, purification, and separation studies, and they, too, were exploited in the 
biomolecular interaction studies. Partial filling affinity capillary electrophoresis (PF-ACE) 
played an especially important role in the research. A particular objective was to explore the 
degree of heterogeneity of the interactions and, for this, help was sought from adsorption 
energy distribution (AED) calculations and other new tools. Computational methods were 
exploited whenever necessary to obtain complementary data at the atomic level. 
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The specific aims of the study were 
o To develop heparin, chondroitin-6-sulfate (C6S), and dermatan sulfate (DS) coatings 
for chip surfaces and heparin coating for fused silica capillary surface. (Papers I, II, 
IV, V) 
o To develop a fast procedure for the preparation of stable and neutral capillary coatings 
for partial filling affinity capillary electrophoresis (PF-ACE). (Paper III) 
o To employ open tubular capillary electrochromatography and a continuous flow quartz 
crystal microbalance (QCM) in the study of interactions between heparin and selected 
lipoprotein nanodomains. (Paper I) 
o To introduce and employ adsorption energy distribution (AED) calculations in the 
data processing step in QCM. (Papers II, IV, V) 
o To study the interactions between C6S and low density lipoprotein particles and their 
peptide fragments by QCM methods, PF-ACE, and molecular dynamics (MD) 
simulations. The effect of temperature was explored. (Papers II, IV) 
o To employ AED calculations in the interpretation of PF-ACE data and compare the 
results obtained for interactions between DS and apolipoprotein E with results 
obtained by QCM technique and microscale thermophoresis (MST). (Paper V) 
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2. Background to the work 
2.1. Miniaturized analytical techniques in the elucidation of biomolecular interactions  
 
Many instrumental techniques and tools are employed in exploring the role of biomolecular 
interactions in physiological and pathological phenomena. This section describes techniques 
currently in use. 
Biological interactions are studied by various biosensors, capillary electrophoresis (CE), 
affinity chromatography, nano liquid chromatography (nano-LC), microscale thermophoresis 
(MST), titration calorimetry, and enzyme-linked immunosorbent assay (ELISA). [1-9] 
Biosensors, CE, nano-LC and MST enable small sample size, low reagent consumption, and 
label-free analysis, all of great advantage relative to more traditional approaches such as 
ELISA and affinity chromatography. The strength of the interactions is determined as affinity 
constants, partition coefficients, retention factors, and reduced mobilities. 
Biosensors for bioanalysis have emerged only during the last two decades but already are 
the method of choice for a variety of studies. The term biosensor was introduced in 1962 by 
Leyland C. Clark, who used it to describe an enzyme electrode. [10] Surface plasmon 
resonance (SPR), which is an optical biosensor, has often been used [11], but also acoustic 
biosensors, such as the quartz crystal microbalance (QCM), have found a place in modern 
biosensing. [8] Both SPR and QCM allow steady state analysis and monitoring of the binding 
process in real time [8, 10-12], and they are widely used for the elucidation of strong 
interactions (dissociation constant (Kd) < 10
-7
 M) such as those between antibody and antigen. 
Moderate-strength (Kd ~10
-7
 – 10-4 M) and weak or very weak (Kd 10
-4
 – 10-1 M) interactions 
are increasingly being measured as well [13, 14]. A distinct advantage of QCM over other 
biosensors is the tremendous amount of information that can be extracted from the acoustic 
impedance measurement, without labeling. This information includes affinity constants, 
changes in viscoelastic properties, cell adhesion processes, and detection of molecules.  QCM 
also provides energy dissipation properties of the mass bound to the surface [8, 15] and it can 
detect changes in mass down to 30 fg/mm
2
. [16] The QCM, as well as other biosensors, have 
been applied to a wide range of biolgocial samples, including lipid membranes, whole cells, 
viruses, and bacteria. [8, 12, 17-19] In this work the focus of the QCM studies was on 
biological interactions of more electrostatic nature, such as peptide–protein and peptide–
carbohydrate. These interactions often exhibit faster dissociation rates and sometimes also 
faster association rates than the interactions between antigen and antibody or between protein 
and receptor, which are more frequently studied by QCM. 
Besides biosensors, miniaturized systems and tools such as capillary electromigration 
techniques and nano-LC are employed in the investigation of biomolecular interactions. [7, 
20]  The interaction studies relying on capillary electromigration techniques usually are 
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carried out in coated capillaries or in capillaries filled with suitable receptor to which the 
binding partner is added. Although open-tubular capillary electrochromatography (OT-CEC) 
is mostly exploited in complex separation studies, it has also proven useful in biomimicking 
studies, after immobilization of the capillary with human material. [21-32] The interactions 
with an immobilized stationary phase are generally evaluated as changes in retention factors. 
As compared with more classical approaches such as liquid chromatography (LC), the 
advantages of OT-CEC are short analysis times, low sample consumption, and broad control 
over the experimental conditions.  
Affinity capillary electrophoresis (ACE) [33-35], and especially partial filling affinity 
capillary electrophoresis (PF-ACE) [36-38], allows dramatically lowered sample consumption 
relative to traditional affinity chromatography. The interference in UV detection experienced 
in ACE does not cause problems in PF-ACE, which means that, so long as the components 
migrate separately, PF-ACE can be used even without the sample purification step. [39, 40] 
PF-ACE is a beneficial probe for biomolecular non-covalent interactions and allows the 
successful determination of binding constants. [40-44] In addition to strong interactions, it can 
be employed for the elucidation of weaker hydrophobic, dipole–dipole, and hydrogen bonding 
interactions. Thus, PF-ACE is often the method of choice for the analysis of pharmaceuticals 
[20, 36, 37, 39, 40, 42, 45-63] and for the chiral recognition needed to verify the purity of 
drugs. [53] Other biological interactions, such as those between protein and carbohydrate, [54, 
64, 65] and biomedical modeling with human samples [57, 63] have also been explored by 
PF-ACE. Recent PF-ACE studies on lipoproteins and drugs under basic conditions suggest 
promising approaches for the determination of affinity constants. [57] 
One significant disadvantage of PF-ACE in biological studies has been the unwanted 
adsorption of positively charged analytes, such as proteins and peptides, onto the uncoated 
capillary inner wall. Numerous polymeric and copolymeric coatings have been developed to 
overcome this problem. [66-69] Coatings also offer an excellent opportunity to manipulate the 
electroosmotic flow for repeatable and reproducible separations, especially for separations of 
large biomolecules. Linear polyacrylamide coatings [70, 71] provide stable and neutral 
coatings over a wide pH range, but the coating procedures themselves are laborious and time 
consuming. Although dynamic coatings are simple to prepare, they lack stability, especially at 
physiological pH. 
Microscale thermophoresis has recently emerged as a good alternative for the investigation 
of biomolecular interactions and a useful tool to complement biosensor studies. [72-75] It has 
been successfully applied to the determination of binding affinities in different systems such 
as protein–protein, protein–peptide, and antibody–antigen. [72, 74] 
The recent integration of fundamental calculations with separation techniques and 
biosensors is offering more detailed insight into binding processes. [76, 77] The exploitation 
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of AED calculations in the data processing step allows determination of the number of 
different binding interactions, the difference in energy of the interactions, and the number of 
interactions per energy level. [76-78] As well, computational interaction studies are 
increasingly being used as complementary tools for visualization of interactions at atomic 
level. [79-81] Both AED and molecular dynamics (MD) simulations complement and support 
the experimental studies.  
Miniaturized techniques and systems have found use in a number of clinical and 
pharmaceutical applications. The development of several diseases is known to be influenced 
by interactions with extracellular matrix components, and furthering our understanding of 
these interactions with the help of flexible and reliable methods will help us to clarify the 
factors affecting these diseases, to develop more effective treatments, and to prevent 
premature deaths. The primary challenge of my work was to apply miniaturized techniques in 
the study of interactions relevant to the initiation of atherosclerosis. 
 
2.2. Role of lipoprotein – glycosaminoglycan interactions in the development of 
atherosclerosis 
The interactions of human plasma lipoproteins with proteoglycans, which are structural 
components of the extracellular matrix (ECM) of the arterial wall, play a key role in the 
development of atherosclerotic plaques. [82-87] Although innumerable studies have been 
targeted at improving our understanding of lipoprotein behavior and the accumulation of 
lipoprotein in the arteries, and many factors influencing the formation of atherogenetic 
plaques have been discovered, the mechanisms and relative contributions of these factors are 
not yet clear.  
 
2.2.1. Extracellular matrix 
The extracellular matrix is a complex, tight, three-dimensional network of macromolecules 
present in all tissues and organs. ECM has an important role not only as a structural 
component but also as a bioactive component that can modulate cellular events. [88] Small 
changes in the structure of ECM can lead to pathological conditions and, reversely, many 
diseases cause changes in ECM. [89] The two main classes of macromolecules in the ECM 
are fibrous proteins and proteoglycans. [89-91]  
Collagen, elastin, and fibronectin are fibrous proteins, which function as a structural 
element, restore the shape of tissues that undergo stretch, and direct the organization of the 
ECM, respectively. [90] Proteoglycans (PG), in turn, consist of a core protein and one or 
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more unbranched glycosaminoglycan (GAG) chains covalently linked to the core. PGs 
participate in binding events and signaling pathways, modulate cell adhesion, and function as 
interstitial tissue by forming a hydrated gel. Classified on the basis of their core proteins, PGs 
comprise small leucine-rich proteoglycans, modular proteoglycans, and cell-surface 
proteoglycans. In this study the focus is on small leucine-rich proteoglycans, which contain 
sulfated glycosaminoglycans. [91] Sulfated glycosaminoglycans — chondroitin-6-sulfate 
(C6S), dermatan sulfate (DS), keratan sulfate (KS), heparan sulfate (HS), and heparin — are 
well known for mediating the retention of lipoproteins in the arterial wall. Besides the 
development of atherosclerosis, they play a contributing role in diseases such as osteoarthritis, 
lung cancer, and breast tumor. [92-94] A thorough understanding of their behavior is crucial, 
therefore, to devising medical responses. 
The applicability of the techniques and methods developed in this study was confirmed in 
studies involving three GAGs (C6S, heparin, and DS) that are highly negatively charged due 
to their sulfate and carboxyl groups and differ from one another in their repeating 
monosaccharide units. These units are composed of N-acetylated or N-sulfated hexoamine 
and of uronic acid (glucuronic acid or iduronic acid) or galactose. [95] C6S is composed of N-
acetylgalactosamine (GalNAc) and glucuronic acid (GlcUA), whereas heparin consists of 
glucosamine and uronic acid. [96, 97]  The structure of DS resembles that of C6S, but DS also 
contains some iduronic acid (IdoA), which gives it similar properties to heparin.  [98-102] 
Iduronic acid, the C-5 epimer of GlcUA, provides flexibility to the DS chain allowing specific 
interaction with proteins and polysaccharides. [99]  
 
2.2.2. Lipoproteins  
Human plasma lipoproteins are globular, nanometer-sized complexes of apolipoproteins and 
lipids. [103-106] Lipoproteins are synthesized in the liver and intestine [103, 107, 108] and 
are responsible for the transportation of cholesterol in the circulation. Very low density 
lipoprotein (VLDL), low density lipoprotein, and intermediate density lipoprotein (IDL) carry 
cholesterol in the circulation and further to the peripheral cells, whereas high density 
lipoprotein (HDL) is responsible for the reverse transport of cholesterol from peripheral cells 
to the liver. [103, 107, 108] The removal of cholesterol from the macrophages in the intima 
walls is a critical anti-atherogenetic step. [104]   
LDL and HDL particles comprise an apolar core of cholesteryl esters, triglycerides, and 
some free unesterified cholesterol, which is surrounded by an amphiphilic shell built up of a 
monolayer of phospholipids containing most of the unesterified cholesterol. The LDL and 
HDL particles are surrounded by apolipoproteins, B-100 and A-I, respectively, and some of 
the HDL particles also contain apolipoprotein E and A-II. [104, 106] Besides composition, 
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LDL and HDL also differ in size. LDLs are 20-25 nm particles, whereas the anti-atherogenic 
HDL particles have an average diameter of 9 nm. [109]   
Apolipoproteins B-100 (apoB-100) and A-I (apoA-I) are needed for the formation and 
metabolism of LDL and HDL particles, respectively. [110, 111] ApoB-100 of LDL is the 
largest known protein, being composed of 4536 amino acids. [110] Several regions of apoB-
100 rich in arginine or lysine have been identified as heparin-binding sites and are mainly 
responsible for the retention of LDL on the arterial wall. [112-114] ApoA-I of HDL is 
considered as anti-atherogenetic [107, 115], whereas apolipoprotein E (apoE) [116] of HDL 
contains arginine and lysine-rich heparin-binding regions, similar in structure to those in 
apoB-100, which mediate the interactions between HDL and GAGs. [117-125] 
ApoE appears in three different isoforms: E2 (apoE2), E3 (apoE3), and E4 (apoE4). These 
are of different genetic origins and, besides atherosclerosis, have been associated with 
Alzheimer disease, healthy aging, and longevity. Apolipoprotein E gene (APOE) has three 
variants, known as ε2, ε3, and ε4, which result in three homozygous genotypes (ε2/ε2, ε3/ε3, 
and ε4/ε4) and three heterozygous genotypes (ε2/ε3, ε2/ε4, and ε3/ε4). [126] Studies on APOE 
alleles have revealed that the ε3 allele is common in all human societies (~ 0.85), ε4 is the 
ancestral allele (0.1–0.407), and ε2 varies with no apparent trend (0.02–0.145). [127, 128] 
Furthermore, an almost linear relationship has been detected between the different genotypes 
and cholesterol levels and coronary risk. [129] APOE (ε2) carriers have 20% lower risk and 
APOE (ε4) carriers 20% higher risk of coronary heart disease than do individuals carrying the 
most common genotype APOE (ε3/ε3).  
 
2.2.3. Atherosclerosis 
Atherosclerosis is an inflammatory disease initiated by the retention and accumulation of 
LDL onto the arterial wall. [85, 130] High levels of LDL play an important role in the 
initiation and progression of atherosclerosis. [131, 132] LDL enters the subendothelial space 
of the arterial wall and, as the primary event in atherosclerosis, is retained on the intima wall 
via electrostatic interactions between negatively charged glycosaminoglycans (GAGs) and the 
positively charged lysine and arginine residues of the lipoprotein. Accumulated LDL can be 
modified by enzymes and oxidized, resulting in aggregation and fusion. [133] Modified LDL 
subsequently is taken up by macrophages, which are transformed into atherogenic foam cells. 
[134] This process strengthens the retention of LDL on the ECM and contributes to the 
pathophysiology of atherosclerosis. [135, 136] 
The inflammatory process has been shown to contribute to the progression of 
atherosclerosis. [137, 138] Modification of LDL results in increased inflammatory burden of 
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the arterial wall, and [139-142] the formation of macrophages can lead to local extracellular 
acidification and increase in local temperature. [143, 144] Acidification is associated with 
wall thickening and the accumulation of lipids in the atherosclerotic lesions, which further 
enhances the affinity of lipoproteins for the arterial wall. [137, 138] This demonstrates a 
contribution of the inflammatory process itself, and of the derived responses, to the 
progression of atherosclerosis. One interesting question, therefore, is whether the elevated 
temperature associated with inflammation is pro-atherogenic and how the elevated 
temperature affects the retention of the lipoproteins. 
GAGs of the arterial wall play a key role in trapping LDL and enhancing thereby the 
development of atherosclerotic diseases. [82-87] The positively charged regions of the 
apolipoproteins attached to the LDL surface are oriented outwards and are important 
modulators of the retention of LDL on the negatively charged sulfate and carboxyl groups of 
GAGs. [145] The accumulation of LDL is thus initiated by the electrostatic interactions 
between the positively charged regions of apolipoprotein apoB-100 and highly negatively 
charged glycosaminoglycans [87, 113, 117, 146] This strong affinity can further the initiation 
of atherogenesis.  
Several of the peptide fragments of apoB-100 exhibit strong affinity for GAGs, the highest 
affinity being measured for the arginine- and lysine-rich peptide fragment 3359-3377, charge 
+6 (apoB-100 peptide). [145] The residue 136-150 of apoE (apoE peptide) of HDL is similar 
in charge distribution (+7) and has been identified as a heparin binding site, which may 
explain the association of apoE and further the accumulation of HDL on arterial PG. [118] 
ApoE has been found localized in the plaque regions enriched with biglycan [125] containing 
1-2 dermatan sulfate chains. [100] 
For the last two or three decades, the instrumental technique of choice for investigating 
proteoglycan–lipoprotein interactions has been affinity chromatography. [124, 147-152] 
Recently, miniaturized techniques, providing lower sample consumption, such as SPR [121, 
149, 153, 154], QCM [13], PF-ACE [57], OT-CEC [21-27], and ellipsometry [155-160], have 
been applied. These provide more detailed information on the interactions, the initiation of 
atherosclerosis, and the formation of atherosclerotic plaques. All the techniques can also be 
applied to the study of various other diseases since, as mentioned above, changes in ECM 
contribute to the development of a number of diseases and, reversely, many diseases induce 
changes in the ECM. [89]  
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3. Techniques used in the study 
The main techniques employed in this study were a biosensor system (QCM), and two 
capillary electromigration techniques (OT-CEC and PF-ACE). MD simulations, atomic force 
microscopy (AFM), and MST were used as supportive or complementary techniques. AED 
calculations were introduced to both QCM and PF-ACE to widen their application to affinity 
studies. 
 
3.1. Continuous flow quartz crystal microbalance 
The continuous flow quartz crystal microbalance is a high-resolution mass sensing acoustic 
biosensor that exploits the piezoelectric effect. [8, 161] The principle of the QCM is 
visualized in Figure 1. The application of an alternating electric field results in shear 
deformation. [15, 162] The fundamental resonant frequency is determined by the thickness of 
the crystal, and generally crystals are cut a few tenths of a millimeter thick in AT form 
(35.25º, angle from the Z-axis). This geometry provides a stable oscillation, and the frequency 
remains stable even under temperature fluctuations. The crystal is sandwiched between two 
metal electrodes, usually gold, through which oscillating potential is applied. Any mass that is 
bound to the surface will tend to oscillate with the same lateral displacement and frequency as 
the underlying crystal. Changes in mass are directly reflected in frequency shifts according to 
the Sauerbrey relation [163], and since the width of the crystal resonance is very narrow the 
changes can be measured accurately at low and high mass ends. Neither the size of molecules 
nor the number of layers affects the changes in frequency when an analyte is interacting with 
the surface. The gold surface can be modified with different functional groups to enable 
covalent immobilization of the molecules of interest as ligands. Analytes in liquid can be 
delivered directly to the QCM electrode surface via syringe or micropipette. In automated 
systems, mechanical influences on the QCM performance can be minimized with flow 
injection analysis systems, which deliver small volumes under laminar flow conditions.  
In QCM experiments the affinity constant (Ka) has traditionally been determined either 
with a Schatchard plot or by kinetic analysis according to Equation 1:  
 
on
off
a
d
k
k
K
K 
1
,     (1) 
 
where koff and kon are dissociation and association rate constants, respectively, when 
ABBA  . For the first time in this work, AED calculations were introduced to QCM, 
where they allowed determination of the affinity constants of heterogeneous interactions.  
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Figure 1. Principle of the QCM. The gold-plated chip functionalized with a ligand is 
presented on the left. After the alternating electric field is applied the crystal resonates at a 
specific frequency. This frequency is directly related to the mass bound to the chip surface, 
and the binding of analytes to the surface is followed as changes in the frequency (on the 
right). 
 
3.2. Capillary electromigration techniques  
Two capillary electromigration techniques were employed in the study of GAG–lipoprotein 
interactions: open tubular capillary electrochromatography (OT-CEC) and partial filling 
affinity capillary electrophoresis (PF-ACE). 
 
3.2.1. Open tubular capillary electrochromatography 
Capillary electrochromatography (CEC) has become an important tool in separation science 
because it is a special case of capillary liquid chromatography, in which movement of the 
mobile phase, through a capillary filled, packed, or coated with a stationary phase, is achieved 
by electroosmotic flow, perhaps assisted by pressure. [164] CEC provides short analysis 
times, low sample and mobile phase consumption, and selective separations of both neutral 
and charged analytes. The major problems in traditional CEC are related to the creation of 
uniform capillary packing and the preparation of fragile frits. Open tubular capillaries are an 
attractive alternative, with neither of the problems mentioned, and the absence of Eddy 
diffusion results in increased separation efficiency. [165, 166] CEC and OT-CEC are methods 
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of choice for many analytes, including biomolecules, pharmaceuticals, and environmental 
compounds. [167, 168] 
In this work the interaction strength was evaluated in terms of the retention factor, k, and 
reduced mobility. The retention factor indicates how strongly the sample component is 
retained by the stationary phase. For uncharged analytes, k can be expressed in terms of 
migration times: 
eo
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       (2) 
where tm and teo are migration times of the analyte and electroosmotic flow (EOF) marker, 
respectively. Rathore and Horvath [169] introduced k′ for the measurement of retention of 
charged analytes in OT-CEC:  
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where k’e is the velocity factor defined as μep/μeo and μep and μeo are the electrophoretic 
mobility of the analyte in the uncoated capillary and the electroosmotic mobility in the coated 
capillary.  Later equation 3 was further modified into the more convenient form [32]  
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where teo’ is the migration time of the EOF marker and tm’ the migration time of the analyte in 
a polyacrylamide (PAA) coated capillary, where coating is used to overcome the adsorption 
problems in the uncoated capillary. 
Better to express relative interactions, the reduced mobility µi, introduced by E. Kenndler 
[170], was used to elucidate relative interactions. 
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where µeff,i is the effective (total) electrophoretic mobility of the analyte.  
 
3.2.2. Partial filling affinity capillary electrophoresis 
Partial filling affinity capillary electrophoresis was developed from ACE to enable the 
analysis of non-covalent interactions with low sample amounts [20, 55] and to exclude 
problems with detection when UV-adsorbing analytes coelute with other species [41]. Partial 
23 
 
filling also allows measurements to be carried out without sample purification. The main 
requirement for PF-ACE analysis is a significant difference in the mobilities of analyte and 
receptor.  
In PF-ACE, short plugs of analyte and receptor are introduced into the capillary and then 
voltage is applied (Figure 2). [37] PF-ACE can be performed by changing the concentration 
of the receptor or the length of the receptor plug introduced to the capillary. The greatest 
advantage of the latter method is the possibility to analyze samples of differing molar 
amounts with the preparation of only one solution. [55] At higher sample volumes, peaks are 
unfortunately broadened and accurate determination of the migration time is more 
challenging. 
 
 
Figure 2. Schematic of PF-ACE method. The capillary is filled with BGE and then short 
plugs of analyte and receptor are introduced into the capillary and voltage is applied. 
 
As noted above, PF-ACE is an effective technique for the evaluation of binding processes. 
[55] In the equation derived from the equations used in ACE for the affinity constant, two 
factors must be taken into consideration: 1) the difference in migration time due to the 
passage of the receptor through the analyte zone [42] and 2) the movement of the analyte 
during analysis, which influences the time during which the receptor and analyte interact. [56] 
The assumption is made that the conductivity and field strength in the capillary remain 
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uniform. [42] The affinity constant can be evaluated from the changes in migration times (Δt) 
as a function of molar amount of receptor [42]: 
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where t0,det is the time needed for the analyte to reach the detector in the absence of receptor 
and Ldet is the effective length of the capillary to the detector. Equation 6 can be modified to 
[57, 58] 
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where VR is the true volume of the receptor zone in the capillary  
appfillingRR VVCV       (8) 
and CR and Vapp are the concentration and apparent volume of the receptor zones. The 
apparent volume can be obtained by field flow fractionation. Vfilling is defined as [57] 
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where tfilling and ttotal are filling time of the receptor and the time required for the receptor to 
reach the detector under 50 mbar pressure. Equations 7–9 can be further modified to  
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3.3. Adsorption energy distribution calculations 
A new tool, AED, was introduced to the data processing step in QCM and PF-ACE to provide 
deeper understanding of the possible heterogeneous interactions between GAGs and 
lipoproteins under different conditions, including different temperatures. An adsorption 
isotherm describes the relationship between the adsorbed and free concentrations of the solute 
at a specific temperature. [77, 78, 171]  
If the Sauerbrey relation is valid, the measured QCM frequency shift is proportional to the 
adsorbed amount of solute. [163] The Langmuir model is the simplest and most popular 
nonlinear adsorption model: 
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where Δf, Δfmax, C, and Ka are the measured QCM frequency shift, maximum frequency shift 
for saturated surfaces, injected solute concentration, and association equilibrium constant, 
respectively. [76] The Langmuir model describes homogeneous interactions from an energy 
perspective. However, adsorption is seldom homogeneous.  The bi-Langmuir model, 
consisting of two independent adsorption sites, which are expressed as the sum of two 
Langmuir terms, is used for heterogeneous interactions.  
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Here, indices 1 and 2 denote the first and second adsorption sites, which are defined as low 
energy and high energy sites, i.e., Ka,2 > Ka,1, respectively.  
The degree of heterogeneity in the binding processes can be calculated by expanding the 
Langmuir adsorption isotherm model into a continuous distribution of independent 
homogeneous sites across a certain range of adsorption energies: 
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where (ln Ka) is the AED and θ(C, Ka) is the local adsorption model. Kmin and Kmax are set to 
1/Cmax and 1/Cmin, respectively, where Cmin and Cmax are the lowest and highest 
concentrations. The AED is calculated by expectation maximization method, where the 
integral equation is discretized to a sum and iteratively solved. [172]  
Before AED calculations can be employed in PF-ACE, the adsorbed fraction of analyte, 
whose concentration is kept constant, needs to be determined as a function of the 
concentration of the receptor. The average mobility of a receptor–analyte complex can then be 
written as [173]: 
bbff
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where θf and θb are the free and bound molar fractions of the analyte, μf and μb are the 
mobilities of the free and bound analyte, and μA is the average mobility of the complex. The 
mobilities of the adsorbed and free molar fractions can be determined by exponential and 
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linear fitting, respectively. [173] Because θf + θb = 1, the equation for the adsorbed molar 
fraction can be written as 
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The Langmuir model, where the solute is reversibly adsorbed, can then be directly expressed 
for PF-ACE as 
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Applying this expression, Equation 13 can be directly exploited to determine the association 
constant and study the heterogeneity of the binding process.  
 
3.4. Molecular dynamics simulations  
Molecular dynamics simulation is a deterministic computational method that enables 
observation of molecular motion of interacting molecules and conformational changes as a 
function of time [174, 175].  Application of MD simulations in interaction studies requires 
that a force field be defined. Force field refers to the functional form and to the parameter sets 
used to describe the potential energy of a system of particles and atoms. The typical set of 
parameters includes atomic mass, van der Waals radius, and partial charges for individual 
atoms. Also needed are equilibrium values of bond lengths, bond angles, and dihedral angles 
and values that correspond to the effective spring constant for each potential. A force field for 
C6S, recently determined in our laboratory, [176] was fortunately available to us. 
Potential of mean force (PMF) calculations are used to evaluate the interaction strength of 
a system and can be applied to derive a free energy calculation and obtain affinity constants. 
PMF is calculated by integrating the mean force from an ensemble of configurations at fixed 
distances between the centers of masses of a pair of molecules. The Ka value can be calculated 
from the PMF using the following equation: [177, 178] 
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where ΔG is the potential of mean force, r is the distance between molecules, R=8.31 
J/mol·K, T=310 K, and Rc is the distance defining the geometric limit of association, a point 
where the interaction of the two molecules is zero.  
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3.5. Microscale thermophoresis 
Microscale thermophoresis is a fast and simple optical technique that can be used to 
determine the affinity constants of biological systems. [72] The movement of particles in a 
temperature gradient is measured from the intensity of fluorescence, which means that one of 
the binding partners must contain a fluorophore or be fluorescently labeled. Thermophoresis 
detects changes in the size, charge, and hydration shell of molecules expressed via Soret’s 
coefficient. An IR laser creates a local temperature gradient, and the degree of binding of an 
analyte can be quantified by measuring the change in the thermophoretic movement of a 
fluorescent molecule along the temperature gradient. 
For determination of the affinity constant, samples must be measured over a wide 
concentration range. The changes in the concentrations are first normalized to the saturation 
value in which all molecules are in bound state. The dissociation constant (Kd) is calculated 
from the law of mass action. The quadratic equation for the fraction of fluorescent molecules 
forming the complex is fitted to the binding curve. [179]  
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where CL0 is the concentration of fluorescent molecules at each data point, CB0 is the 
concentration of added titrant, and CBL is the concentration of the formed complex.  
 
3.6. Atomic force microscopy 
In atomic force microscopy (AFM), the surface topography of a sample is measured and 
visualized in either 2D or 3D. AFM also provides qualitative and quantitative information on 
a sample’s physical properties, such as size, morphology, surface texture, and roughness. A 
wide range of samples with different properties can be studied, from hard surfaces to 
biological samples, such as cells. [180] AFM measures changes in the forces between a probe 
mounted on a flexible cantilever and the surface of the sample as  the probe is guided over the 
surface.  [180-183] The most common modes of operation are contact and tapping. In the first 
the probe is in contact with the sample and in the latter it oscillates up and down as the surface 
is scanned. The tapping mode is well suited for biological samples. [184]   
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4. Experimental  
This section describes the chemicals (Table 1), buffers (Table 2), instruments and other 
equipment (Table 3), and methods and experimental conditions used in the study. 
 
Table 1. List of chemicals 
Compound Supplier Notes Paper 
11-Mercaptoundecanoic acid (11-MUA) Sigma-Aldrich  IV 
1-Ethyl-3-(3-dimethylaminopropyl) carboimide 
hydrochloride (EDC) 
Sigma-Aldrich  I, II, IV, V 
2-Mercaptoethanol Sigma-Aldrich  V 
3-(Trimethoxysilyl)propyl methacrylate Sigma-Aldrich  I, II 
3-Aminopropyltriethoxysilane (APTES) Sigma-Aldrich  I 
4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) 
Sigma-Aldrich  II, IV, V 
Acetic acid Merck  I, III, IV ,V 
Acetone Mallinckrodt Baker   I 
Acrylamide Merck  I, II 
Alprenolol Sigma-Aldrich pKa 9.4,  
Mr 285.81 
III 
Ammonium persulfate Merck  I, II 
ApoB-100 peptide * Mr 2133  I, II, IV 
ApoE peptide * Mr 1923.5 I, II, V 
Atenolol Sigma-Aldrich pKa 9.4,  
Mr 266.32 
IV 
Bovine serum albumin (BSA) Sigma Aldrich  III, V 
Carbohydrazide Fluka   IV, V 
Chicken egg white lyzozyme Sigma Aldrich pI 10,  
Mr 14 300 
III 
Chloroform-d Sigma-Aldrich  III 
Chondroitin-6-sulfate Sigma-Aldrich Mr 56 000 II, IV 
Dermatan sulfate Sigma-Aldrich  V 
Dimethyl sulfoxide(DMSO) LabScan and FF-
Chemical Ab 
 I, II, III, IV,  
V 
Dimethylformaldehyde (DMF) Sigma Aldrich  III, V 
Ethylene diamine Sigma-Aldrich  II 
Ethylenediaminetetraacetic acid (EDTA) Sigma Aldrich  III, V 
Heparin  Sigma-Aldrich, 
Innotrac Diagnostic 
 I 
Horse heart cytochrome C Sigma Aldrich pI 9.6,  
Mr 12 400  
III 
Hydrochloric acid (1.0 M) Oy FF-Chemical Ab  I, III, IV, V 
 
29 
 
Table 1. (Continued) 
KBr Sigma-Aldrich  I, III, V, 
Methanol VWR Chemicals  I, II 
Methyliodide (MeI) Sigma Aldrich  III, V 
Metoprolol Sigma Aldrich pKa 9.5, 
 Mr 267.36  
III 
N,N,N’,N’-Tetramethylethylenediamine Biorad laboratories  I, II 
NaCl J.T.Baker  I, II, IV, V 
NH4HCO3 Sigma-Aldrich  V 
N-Hydroxysulfosuccinimide sodium salt (sulfo-NHS) Sigma-Aldrich  II 
pET32a(+) vector Novagen  V 
Phosphate-buffered saline (PBS) Sigma-Aldrich Tablets IV, V 
Phosphoric acid VWR and Merck  I, II, III, V 
Pindolol Sigma Aldrich pKa 8.8,  
Mr 248.32  
III 
Poly(2-vinylpyridinine–block–ethylene oxide)  
(P2VP-b-PEO) 
Polymer Source inc. 
124 Avro Street, 
Dorval (Montreal) 
QC, Canada 
Mn,P2VP=3000 
 Mn,PEO= 
10 000 
 Mw/Mn=1.13 
III, IV, V 
Propranolol Sigma-Aldrich pKa 9.5,   
Mr 295.8  
III 
Sodium acetate Fluka   I 
Sodium cyanoborohydride Fluka  IV, V 
Sodium hydroxide (1.0 M) Oy FF-Chemical Ab  I, III, IV, V 
Sodium metaperiodate Sigma-Aldrich  IV, V 
Urea Sigma-Aldrich  V 
α-Chymotrypsinogen A Sigma Aldrich pI 9.3,  
Mr 25 000  
III 
* Peptide fragments (apoB-100 peptide: RLTRKRGLKLATALSLSNK, +6, and apoE 
peptide: RLASHLRKLRKRLLR, +7) were synthesized at the Meilahti Protein Chemistry 
Facility, Biomedicum, University of Helsinki, Finland.  The purification was carried out in a 
C18 reversed-phase column (Supelco) with 10 column volumes of ACN/H20 gradient, 0 to 
70% (v/v). Protein was analyzed at the Protein Chemistry Core Facility, Biomedicum, 
University of Helsinki, Finland, by matrix-assisted laser desorption/ionization tandem time-
of-flight mass spectrometry (AutoFlex III). [22]   
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Table 2. List of buffer solutions* 
Buffer pH 
Ionic 
strength 
[mM] 
Salt added Paper 
Acetate  4.0 10  II, IV, V 
Acetate  4.0 20  I, III 
Acetate  4.5 10  III 
Acetate  4.5 20  I, III 
Acetate  4.5 70  III 
Acetate  5.0 20  I 
Acetate  5.5 10  III, IV, V 
Acetate  5.5 20  III 
Acetate  5.5 70  III 
Borate 8.5 20  III 
Borate 9.5 20  III 
HEPES  7.4 10 150 mM NaCl II, IV, V 
Phosphate  5.5 20  I, III 
Phosphate  5.5 20 25 mM NaCl I 
Phosphate  6.5 10  III 
Phosphate  6.5 20  I, III 
Phosphate  6.5 70  III 
Phosphate  7.4 10  III 
Phosphate-buffered saline 7.4. 10 2.7 mM KCl, 137 mM NaCl IV, V 
Phosphate  7.4 10 25 mM NaCl IV 
Phosphate  7.4 20  I, II, III, IV, V 
Phosphate  7.4 20 25 mM NaCl I, II 
Phosphate  7.4 20 40 mM NaCl II 
Phosphate  7.4 70  III 
Phosphate  10.5 20  III 
*The pH of the buffers was adjusted with 1.0 M NaOH and 1.0 M HCl and the buffers were 
filtered through 0.45 μm Millipore filter. 
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Table 3. List of instruments and equipment 
Equipment Model and manufacturer Notes Paper 
Atomic force microscope Multomode V, Veeco  III 
C18 reversed-phase column Supelco Discovery wide-pore  IV 
CE Hewlett-Packard 3
D
 CE system Diode array detector 
coupled with air-
cooling device 
I, II, III, 
IV, V 
Escherichia coli BL21 (DE3) 
bacterial system 
New England Biolabs Inc  V 
    
FT-IR spectrometer Nicolet 388, Thermo Scientific  III 
Gold-plated chips Attana AB  IV 
His-Bind Resin Chromatography Kit Novagen,  V 
HiTrap Heparin purification column Amersham Biosciences  V 
Low nonspecific binding (LNB) 
carboxyl-coated gold chips 
Attana AB  II, IV, V 
MALDI-TOF/TOF MS AutoFlex III, Bruker  I, II, IV 
Millipore filters Bedford 0.45 µm I, II 
Millipore water purifier Millipore S. A.  I, II, III, 
IV, V,  
Monolith NT.115™ hydrophilic 
capillaries 
NanoTemper Technologies 
GmbH, Munich, Germany 
 V 
Monolith NT.LabelFree NanoTemper Technologies 
GmbH, Munich, Germany 
 V 
NMR spectrometer AVANE DPX499, Bruker 
1
H-NMR III 
pH meter Jenway 3030  I, II, III 
pH meter MeterLab PHM 220, Radiometer  I, IV, V 
Quartz crystal microbalance (QCM) 
 
Attana A-100, Attana AB  I, II, IV, 
V 
SiO2 chips Attana AB  I 
Ultracentrifuge 50.2. Ti rotor (302 000 gmax), 50.2. 
Ti rotor (148 000 gmax) ,  
80 Ti rotor (115 000 gmax)  
Beckman Coulter 
 I 
Uncoated fused silica capillaries Optitronics GmbH 50 µm inner 
diameter (i.d.), 375 
µm outer diameter 
(o.d.)  
II, IV, V 
Uncoated fused silica capillaries Composite Metal Services Ltd. 50 µm i.d., 375 µm 
o.d. 
I 
Uncoated fused silica capillaries Polymicro Technologies 50 µm i.d., 375 µm 
o.d. 
III 
Water bath Lauda Ecoline Re-104  I, III 
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4.1. Isolation of lipoproteins  
Human LDL (d = 1.019–1.050 g/mL) was isolated from the human plasma of healthy 
volunteers (Finnish Red Cross, Helsinki, Finland) by sequential ultracentrifugation in the 
presence of 3 mM EDTA. [112] Solid KBr was added to plasma to adjust the density to 1.019 
g/mL. The floated VLDL and IDL fractions were removed, and the density of the supernatant 
solution was adjusted to 1.050 g/mL with solid KBr. After ultracentrifugation for 72 h at 35 
000 rpm in a Beckman Coulter-type 50.2 Ti rotor (148 000 gmax), LDL was recovered from 
the top of the centrifuge tubes and recentrifuged (d = 1.060 g/mL) for 24 h at 35 000 rpm in a 
Beckman Coulter-type 80 Ti rotor (115 000 gmax), and dialyzed extensively against LDL 
buffer (1 mM EDTA and 150 mM sodium chloride in water, pH 7.4, adjusted with sodium 
hydroxide). The amount of LDL, expressed in terms of its protein concentration, was 
determined by the method of Lowry et al. [185] with BSA as standard. (Papers I, III, IV) 
Human VLDL (d = 1.006 g/mL) was isolated from the plasma of healthy volunteers by 
ultracentrifugation, with EDTA added as an anticoagulant. The VLDL was dialyzed against 
VLDL buffer (1 mM EDTA and 150 mM sodium chloride in water, pH 7.4 adjusted with 
sodium hydroxide). The amount of VLDL, expressed in terms of its protein concentration, 
was determined by the method of Lowry et al. [185] with BSA as standard. (Paper III) 
Human HDL2 (d = 1.063–1.125 g/mL) and HDL3 (d = 1.125 –1.21 g/mL) particles were 
isolated by sequential density ultracentrifugation. [186] Densities were adjusted in each 
centrifugation step with solid KBr. The HDL subclasses were washed by reflotation at their 
upper density (1.125 g/mL for HDL2 and 1.21 g/mL for HDL3). All of the centrifugation steps 
were carried out at 50 000 rpm in a Beckman Ti 50.2 rotor (302 000 gmax) for 40 h at +5 °C. 
HDL and its subclasses were dialyzed against sodium phosphate buffer (20 mM phosphate-
buffered saline, pH 7.4) containing 140 mM NaCl to remove KBr. The dialyzed HDL 
subclasses were stored at +4 ºC. Protein and lipid compositions of the isolated HDL particles 
(%, m/m) were determined by standard methods. [187] (Papers I, III) 
HDL with and without apoE was purified by heparin affinity chromatography by a 
modification of the reported method. [188] The HiTrap Heparin–Sepharose column was 
equilibrated with 5 mM Tris-HCl/50 mM NaCl, pH 7.4, with a flow rate of 0.5 mL/min. Solid 
MnCl2 was added to the HDL solution just before application to the column to give a final 
Mn2
+
 concentration of 25 mM, and the column was equilibrated with 5 mM Tris-HCl/50 mM 
NaCl, pH 7.4, containing 25 mM MnCl2. Next, HDL (1–2 mg as protein, to which MnCl2 had 
been added) was applied to the column, and the column was washed with 5 mM Tris-HCl/50 
mM NaCl/25 mM MnCl2, pH 7.4, until the A280 dropped to the baseline. The apoE-free HDL 
particles not bound to heparin were then collected. The heparin-bound apoE-containing HDL 
was detached from heparin and eluted with 5 mM Tris-HCl/100 mM NaCl, pH 7.4, and 
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collected in 1 mL fractions. The nonbound fractions (representing apoE-free HDL) and the 
bound fractions (representing apoE-containing HDL) were separately pooled, dialyzed against 
PBS, and stored at +4 °C until use. ApoE was analyzed in isolated HDL pools by 
immunoplotting and ELISA. (Paper I) 
 
4.2.  Production and purification of apoE  
Constructs of apoE were a gift from Dr. Karl H. Weisgraber (Gladstone Institute of 
Cardiovascular Disease, San Francisco, CA). The cDNAs for human apoE2 and apoE3 were 
cloned into a modified pET32a(+) vector, which encodes an N-terminal His6 tag and a fusion 
partner, thioredoxin. [189] Recombinant apoE was produced in an Escherichia coli BL21 
(DE3) bacterial system and purification was performed with an His-Bind Resin 
Chromatography Kit by a reported method. [189] Thrombin digestion was carried out at room 
temperature for 30 min at a ratio of 1:500 (thrombin: apoE, w/w). Delipidation of apoE was 
done as described previously. [190] The final purification of apoE was performed by 
Heparin–Sepharose affinity chromatography (HiTrap Heparin). Briefly, the delipidated apoE 
was first diluted in PBS containing 5 M urea and 0.1% of 2-mercaptoethanol, pH 7.4. The 
apoE sample was then loaded onto a 5 mL heparin–Sepharose column equilibrated with the 5 
M urea buffer at a flow rate of 1 mL/min. Bound apoE was eluted with 1 M NaCl in 5 M urea 
buffer. Eluted apoE was dialyzed against 100 mM NH4HCO3, pH 8.0. Purified apoE3 and 
apoE3 isoforms displayed one band, staining in SDS–PAGE analysis with an apparent 
molecular mass of 34 000. (Papers I, V) 
 
4.3.  Quaternization of P2VP-b-PEO  
The unmodified block copolymer P2VP-b-PEO was quaternized to poly(N-methyl-2-
vinylpyridinium iodide–block–ethylene) (P2QVP-b-PEO) before the capillary coating. 
(Papers III, IV, V) P2VP-b-PEO (10.5 mg) was dissolved in 3 mL of DMF, and an excess (60 
equivalents) of MeI was added dropwise to the block copolymer solution. The reaction was 
carried out at ambient temperature for three days in darkness with constant stirring. The 
excess of the MeI and part of the DMF were evaporated with a rotary evaporator. The 
remaining solution was dialyzed against Milli-Q water for three days using a dialysis sack 
(MWCO 2000/ 3500) and finally lyophilized for two days. Spectral characterization by 
1
H-
NMR in CDCl3: δ (ppm): A-D: 6.9 - 8.5 (CH, 2VP cycle), G: 3.6 (CH2 PEO), H: 3.5 (N-CH3 
P2QVP), E-F: 0.9-3 (CH2, CH, 2VP).  
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4.4.  Coating methods 
The development of biomimicking systems for CE and QCM requires the immobilization of 
biomolecules onto the capillary inner surface and chips, respectively, and, in the case of PF-
ACE, modification of the capillary inner surface with polymeric material to create a neutral 
surface. Several coating methods were explored in recognition of these needs. The starting 
materials for the coating procedures (fused silica, gold, carboxyl- or SiO2-functionalized gold) 
were preatreated or pre-wetted before the coating.  
 
4.4.1. Pretreatment of capillaries and quartz crystal chips 
A pretreatment step was included to remove impurities from capillary and chip surfaces and 
to improve the immobilization. The pretreatment procedures employed are presented in Table 
4. 
 
Table 4. Pretreatment procedures for the fused silica capillaries and gold-plated quartz 
crystal chips. 
 Pretreatment procedure Temperature Notes 
Before the PAA 
coating in capillary 
(Papers I, II) 
5 M HCl 30 min 
Milli-Q water 30 min 
5 M NaOH 30 min 
Milli-Q water 30 min 
Ambient In situ 
Before the P2QVP-
b-PEO coating in 
capillary 
(Papers III, IV, V) 
1 M HCl 20 min  
0.1 M HCl 10 min  
Milli-Q water 25 min  
Phosphate buffer (I=20 mM, pH 7.4) 5 min 
25 ºC, CE 
temperature 
control, 
ambient* 
In situ 
In a vial* 
Before the APTES-
heparin coating in 
capillary (Paper I) 
1 M NaOH 15 min 
Milli-Q water 15 min  
Acetone 15 min 
37 ºC,  
CE temperature 
control 
In situ 
SiO2 chip 
(Paper I) 
1 M NaOH 20 min,  
Milli-Q water 15+15 min  
Acetone 15 min 
37 ºC,  
water bath 
Ex situ  
in a vial 
Gold chip 
(Paper IV) 
H2O:NH2:H2O2 (5:1:1, v:v:v) 10 min  
Milli-Q water, EtOH 
70 ºC, sand bath 
Ambient 
Ex situ in a 
beaker** 
LNB carboxyl chip 
(Papers II, IV, V) 
Milli-Q water 10 min Ambient Ex situ in a 
chip holder 
*In a vial before the AFM measurement, ** The beaker was washed three times with 
H2O:NH2:H2O2 (5:1:1, v:v:v) for 20 min at 70 ºC before  the pretreatment of the chip. 
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4.4.2. Functionalization of the capillary wall 
Fused silica capillaries were freshly coated before each interaction experiment. In the PF-ACE 
studies, coatings were needed to create neutral surfaces to avoid unwanted analyte adsorption 
onto the capillary wall, while in the OT-CEC studies they were needed to immobilize heparin 
on the capillary surface. Two materials were employed for the neutral coatings: polyacrylamide 
(Papers I and II) and a new block copolymer P2QVP-b-PEO (Papers III, IV and V).  
 
4.4.2.1. Preparation of neutral capillary surface 
Polyacrylamide coating   
The coating procedure for polyacrylamide was that described by Cifuentes et al. [71] slightly 
modified. After the pretreatment the capillary was purged with N2 gas at 265 °C for 2 h, then 
flushed for 1 h with a solution containing 5 μL of acetic acid, 5 μL of 3-(trimethoxysilyl)propyl 
methacrylate, and 1 mL of methanol. Next, the capillary was rinsed with methanol for 30 min. 
Lastly, it was filled with a fresh solution of acrylamide containing N,N,N’,N’-
tetramethylethylendiamine and ammonium persulfate. Both ends of the capillary were sealed 
and the capillary was left to polymerize for 16 h, after which it was washed with water and 
buffer. (Papers I and II) 
 
Block copolymer coating  
Block copolymer P2QVP-b-PEO was attached to the negatively charged capillary wall via 
quaternized P2QVP block. The capillary was flushed with 0.1 mg/mL block copolymer 
solution for 40 min and left to stand for 30 min. The excess of the P2QVP-b-PEO solution 
was then flushed with background electrolyte (BGE) solution for 60 min. (Papers III, IV, V) 
For the AFM studies undertaken to visualize the topography of the coated capillary, the outer 
wall of the capillary was coated. For this, the, polyimide layer of the outside wall of the fused-
silica capillary was burned off, after which the same coating procedure as for the inner surface 
was applied except that the coating was done in vial. The pretreated capillary was allowed to 
react with the block copolymer solution (c=0.1 mg/mL) for 60 minutes, then left to stand for 
60 minutes in 20 mM phosphate buffer at pH 7.4.   
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4.4.2.2. Preparation of APTES–heparin coating  
The coating with APTES and heparin was optimized for the fused silica capillaries used in 
PF-ACE, and the optimized procedure was then further applied to the SiO2 chip surfaces used 
in QCM measurements. (Paper I) After the pretreatment step, the capillary was flushed with 
4% (v/v) APTES solution in acetone at 50 mbar for 30 min and left to stand filled with the 
silanization solution for 16 h. Next, the capillary was flushed with acetone for 10 min, with 
water for 5 min, and with phosphate buffer at pH 5.5 for 60 min to eliminate the unbound 
APTES. Two methods were tested for immobilization of heparin on the APTES-modified 
capillary. The first was direct immobilization, in which the capillary surface was treated with 
heparin solution at 50 mbar for 40 min, and the capillary was left to stand filled with the 
coating solution for 15–60 min, and flushed with phosphate buffer at pH 7.4 for 15 min. The 
second method was covalent immobilization, carried out according to Stege et al. [191] 
Heparin solution (3 mg/mL) dissolved in 2 mL phosphate buffer, pH 7.4 (I = 20 mM), 
containing 0.25 mg of EDC was flushed through the capillary for 1 h. Lastly, the capillary 
was rinsed with phosphate buffer at pH 7.4 to remove the unbound heparin. 
 
4.4.3. Immobilization of GAGs on gold-plated quartz crystal chips 
GAGs were immobilized on gold, SiO2, and LNB carboxyl surfaces by different coupling 
methods (Table 5). Amine and aldehyde coupling was performed in situ with Attana A-100, 
and APTES and 11-MUA linkers were attached ex situ. Figure 3 presents a schematic image 
of the immobilization of dermatan sulfate via aldehyde coupling onto LNB carboxyl surface.  
 
Table 5. Coupling methods employed for the immobilization of GAGs on gold-plated chips. 
Immobilized 
GAG 
Chip employed Coupling method Notes 
 
C6S 
(Papers II, IV) 
LNB carboxyl 
Aldehyde coupling 
Amine coupling 
In situ 
Gold 
11-MUA linker – amine 
coupling 
Ex situ (11-MUA), in 
situ (amine coupl.) 
DS 
(Paper V) 
LNB carboxyl Aldehyde coupling In situ 
Heparin 
(Paper I) 
SiO2 APTES linker Ex  situ 
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The coupling procedures required 0.2 M EDC solution in HEPES, 0.05 M sulfo-NHS in 
HEPES, 5 mM carbohydrazide in HEPES, 0.05 mg/mL C6S solution in acetate buffer (pH 4), 
0.1 M cyanoborohydride in acetate buffer (pH 4), 10 mM 11-MUA in ethanol, and 0.5 mg/mL 
ethylene diamine (solution pH 8.5). For the aldehyde coupling, C6S and DS were oxidized for 
16 and 3 hours, respectively, by adding 2 mg of sodium metaperoxide to 1 mL of the C6S or 
DS solution (8 mg/mL) prepared in acetate buffer (pH 5.5). The coupling of GAGs on the 
chip surface was carried out according to the manufacturer’s instructions. 
In both amine and aldehyde couplings the pre-wetted chips were inserted into the 
instrument and left to stabilize in the HEPES (pH 7.4, I = 10 mM + 150 mM NaCl) as running 
buffer. The flow rate during the immobilization step was set to 10 μL/min. The surface was 
first activated with three injections (400 s) of a freshly prepared mixture (1:1, v:v) of EDC 
and sulfo-NHS solutions.  
In amine coupling, C6S was attached to the activated surface by making two injections 
(200 s) of C6S (0.05 mg/mL, in acetate buffer pH 4), followed by a deactivation step 
comprising injection of ethylene diamine solution (three times, 400 s each). In aldehyde 
coupling, after the activation step 5 mM carbohydrazide was injected three times for 200 s 
each followed by six injections of the ox-C6S or ox-DS for 350 s each. Unbound ox-C6S (or 
ox-DS) was deactivated by injection of sodium cyanoborohydride (0.1 M) for 200 s. 
Study of interactions between LDL and C6S required a special regeneration step for the 
chip: C6S was coupled to gold chip via 11-MUA, as previously employed for the 
immobilization of DNA on gold surfaces. [192] The immobilization of 11-MUA was carried 
out according to the manufacturer’s instructions. After pretreatment the chip was left to 
incubate at 4 ºC for 24 h in a vial containing 10 mM 11-MUA solution in ethanol. The chip 
was rinsed with EtOH and milli-Q water before it was inserted to the instrument. C6S was 
coupled to 11-MUA by amine coupling method as described above. 
Heparin was attached to the SiO2 surface ex situ in a vial by a method [191] adapted from 
the capillary coating, in which APTES was used as a linker between negatively charged 
heparin and the capillary wall. After pretreatment the SiO2 surface was modified with APTES 
at 37 ºC as follows: the chip was left to react with 4% (v/v) APTES solution in acetone for 16 
h at 37 ºC, then rinsed with acetone for 20 min, with milli-Q for 15 min, and with phosphate 
buffer (I = 20 mM), pH 5.5, and 25 mM NaCl for 15 min. Heparin was then covalently 
attached to the APTES-modified surface. The SiO2 chip was left to react with the heparin (3 
mg/mL) solution dissolved in 2 mL phosphate buffer, pH 7.4 (I = 20 mM), containing 0.25 
mg of EDC for 2 h. Finally, the chip was rinsed with phosphate buffer at pH 7.4 to remove the 
unbound heparin. 
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Figure 3. Immobilization of DS by aldehyde coupling on LNB carboxyl surface for study of 
DS–apoE peptide interaction. 
 
4.5.  Evaluation of the capillary coating 
The capillary coatings used in OT-CEC and PF-ACE were evaluated by EOF measurements 
before their application to interaction studies and, after the P2QVP-b-PEO coating, by 
visualizing the surface topology by AFM. 
 
4.5.1. Electroosmotic flow measurements 
EOF marker DMSO (0.05 %, v/v) was used as an indicator of the stability of the coating in 
different stages of the coating procedure and between runs. Before each EOF measurement 
the capillary was equilibrated with BGE. After modifications with APTES and heparin, EOF 
was measured with DMSO as EOF marker by using 2 s (50 mbar) injection and +20 kV 
voltage. The method developed by Williams and Vigh [193] was employed for EOF 
measurements of neutral PAA and P2QVP-b-PEO coatings according to Eqs. 19-21.  
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where Leo is the distance the EOF markers move during the electrophoresis: 
     mNNNNeo vttttL 1223      (20) 
and vm is the final pressure mobilization velocity: 
dinjN
m
ttt
L
v


23
det      (21) 
and Ltot and Ldet are the total length of the capillary and the length to the detector,  tN1, tN2 and 
tN3 are the migration times for the EOF marker, tinj is the injection time, td is the possible 
delay, Vprog is the separation voltage for the migration time (tm), and tramp-up and tramp-down are 
the times for the change in voltage between 0 and the separation voltage (Vprog). 
 
4.5.2. Separation of model analytes 
As well as by EOF measurements, the neutral P2QVP-b-PEO coating was evaluated in 
separations of three sets of model analytes: lipoproteins, cationic proteins, and beta-blockers. 
Run conditions were as follows: voltage +25 kV, inj. 1 s (50 or 30 mbar), temperature 25 or 
37 ºC, Ldet 30 cm, and Ltot 38.5 cm, i.d. 50 µm. Detection was done at 200 nm. Coated 
capillaries were flushed (1 bar) with BGE for 2 to 5 min between runs. Lipoproteins were 
separated at physiological pH 7.4 (phosphate buffer, I = 20 mM), positively charged proteins 
at pH 4.0 (I = 20 mM), and beta-blockers at pH values 7.4, 6.5, 5.5, 4.5. Beta-blockers were 
diluted in appropriate buffer (I = 10 mM) and with BGE (I = 70 mM). 
 
4.5.3. Atomic force microscopy measurements  
The surface topography and the orientation of the block copolymer P2QVP-b-PEO on the 
capillary surface were visualized by AFM. Images from a scanning area of 2 µm x 2 µm were 
captured immediately after the coating step at ambient temperature and humidity (T = 21±1 
ºC and RH = 21%) with Veeco RFESP rectangular phosphorus-doped Si cantilevers (k = 3 
N/m), using nominal resonance frequency of 75 kHz and a nominal tip radius of 10 nm. A 
line frequency of 0.5 Hz was used for imaging. (Paper III) 
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4.6. Quartz crystal microbalance measurements 
QCM measurements were performed to determine binding constants between GAGs and LDL 
and selected peptide fragments. The measurements were carried out with an Attana A100 
QCM biosensor, where the quartz crystal was sandwiched between two gold-plated 
electrodes. The integrated c-fast and Attester programs were used for sample injection and 
recording the frequency shifts (Δf) due to binding of the analyte to the surface. The sample 
was injected by loading the injection loop, and then the valve was switched to enable the 
transport of the sample to the sensor surface. After the injection the valve was switched back 
and the running buffer was again transported to the surface, and changes in the frequency 
shifts due to the binding process were recorded. A piston pump enabled constant flow (25 
µL/min) of the running buffer over the crystal surface placed inside the flow cell (dimensions: 
diameter 6 mm, height 0.05 mm, volume about 1.4 μL). All samples were dissolved and 
diluted in the phosphate buffer (I = 20 mM, pH 7.4 + NaCl) used in the QCM measurements. 
Injection volume was 35 µL and triplicate measurements were performed for each 
concentration. After each sample injection the surface was regenerated with appropriate 
solution. Details of the experimental conditions are collected in Table 6. 
 
Table 6. Experimental conditions in QCM experiments  
Ligand – analyte  
Concentration of 
salt in the phos. 
buff. 
Regeneration 
solution 
Concentration 
range of the 
analyte [μg/mL] 
Temperature 
[ºC] 
C6S – apoB-100 
peptide 
(Papers II, IV) 
40 mM NaCl (II) 
2.7 mM KCl, 137 
mM NaCl (IV) 
1 M NaCl (II) 
2 M NaCl 
(IV) 
5 – 200 (I) 
5 – 320 (IV)  
25, 28, 34, 37, 
38, 39, 40 
C6S – apoE 
peptide (Paper II) 
25 mM  1 M NaCl 1 – 130  25 and 37 
C6S – LDL  
(Paper IV) 
2.7 mM KCl, 137 
mM NaCl (IV) 
* 1 – 5   
37, 38, 39 and 
40 
DS – apoE 
peptide (Paper V) 
2.7 mM KCl, 137 
mM NaCl 
2 M MgCl2 0.5 – 150  25 
Heparin – apoB-
100 peptide 
(Paper I) 
25 mM NaCl 0.4 M NaCl 8 – 40  25 and 37 
Heparin – apoE 
peptide (Paper I) 
25 mM NaCl 0.4 M NaCl 13 – 50  25 and 37 
* The gold chip was cleaned ex situ with H2O:NH2:H2O2 (5:1:1, v:v:v) at 70 ºC  
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Three different methods were employed for estimation of the affinity constant: AED 
calculations and Scatchard plot analysis, which employ steady state analysis, and kinetic 
analysis. The Scatchard plot analysis and kinetic analysis do not distinguish heterogeneous 
binding, and AED calculations were employed to enable this. ClampXP software [194] was 
used to estimate the interaction strength between C6S and human LDL. A steady-state 
approach was selected for each peptide–GAG adsorption system, since this enabled 
determination of the heterogeneity of the binding process. 
 
4.7. Capillary electrophoretic measurements 
The interactions were studied by two capillary migration techniques: OT-CEC, in which the 
ligand was immobilized on the capillary wall, and PF-ACE, in which both analyte and 
receptor were moving freely in the capillary. 
 
4.7.1. Open tubular capillary electrochromatography  
In OT-CEC studies, the affinity of apoE and apoB-100 peptides, LDL, HDL2 (with and 
without apoE), and apoE for the heparin-coated capillary wall was analyzed in terms of 
retention factors (Eq. 4) and reduced mobilities (Eq. 5) at physiological temperature. (Paper I) 
Analytes were injected hydrodynamically for 2 s at 50 mbar, and +20 kV voltage was applied. 
The mobilities of the peptide fragments were measured in PAA-coated capillaries [193] to 
avoid interactions between the positive peptides and negatively charged capillary wall. The 
capillary was flushed with 20 mM phosphate buffer (pH 7.4) for 2 min between runs.  
  
4.7.2. Partial filling affinity capillary electrophoresis  
PF-ACE was employed to study the interactions of LDL, apoE peptide, and apoB-100 peptide 
with C6S and the interactions of apoE with DS. (Papers II, IV, V) The capillary was first 
partially filled with peptide or lipoprotein and then an increasing molar amount of C6S or DS 
was injected, causing a shift in the migration time of the analyte. [20] Binding constants were 
obtained according to our previous studies [57] using equation 10. Unfortunately, this method 
did not distinguish multiple binding sites and therefore AED calculations were also 
introduced for PF-ACE. 
Phosphate buffer (pH 7.4, I = 20 mM) was used as running buffer in all systems. Other 
experimental parameters are presented in Table 7. When voltage was applied, negatively 
charged LDL, apoE, DS, and C6S began to move toward the detector at the anode end, while 
42 
 
the positively charged peptides began to move toward the inlet at the cathode end. Since C6S 
and DS are more negatively charged than LDL and apoE, the LDL and apoE are overtaken 
and interaction occurs between GAGs and the lipoproteins. C6S and peptides have opposite 
mobilities, and after the voltage is applied they meet and interact with each other. Detection 
was at wavelengths 200 and 214 nm, and the capillary was flushed with BGE for 2 min 
between runs. 
 
Table 7. Experimental conditions for PF-ACE experiments. 
Analyte – receptor  Concentration 
[mg/mL] 
Voltage 
[kV] 
Injection time  
[s] press. 50 mbar 
Temperature 
[ºC] 
Peptides – C6S 
(Paper II) 
Peptide: 0.01  
C6S: 1.0 
- 20 
Peptide: 5 
C6S: 10, 15, 20, 25, 
30 
37  
LDL – C6S 
(Paper IV) 
LDL: 0.1  
C6S: 0.6  
- 25  
LDL: 2 
C6S: 1, 2, 3, 4, 5, 6 
37, 38, 39, 40 
ApoE2/3 – DS    
(Paper V) 
ApoE2/3: 0.05 
DS: 0.002  – 0.8 
- 20  
ApoE: 1 
DS: 3  
25  
 
 
4.8. Adsorption energy distribution calculations for processing QCM and PF-ACE 
data  
Each adsorption isotherm was acquired under a broad concentration range of the solute, since 
different adsorption sites dominate at different concentration levels. A three-step procedure 
was used before the model selection (Figure 4). [76-78] (Papers II, IV, V) First, preliminary 
insight into the adsorption characteristics was obtained by Scatchard plot analysis (plotting 
Δf/C vs Δf); then the degree of heterogeneity and number of different adsorption sites were 
determined by AED using the expectation maximization method to reduce the number of 
possible adsorption isotherm models. [172] Finally, rival models were fitted to the raw data 
and statistical evaluation was done with the F-test (95%). This three-step procedure facilitates 
the selection of a proper adsorption model and, compared with the use of Scatchard plots 
alone, provides a much truer estimate of the interactions. The AED step can reveal the 
heterogeneous adsorptions concealed in linear Scatchard plots when energies of adsorption 
are weak at the secondary sites. [195]  
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Figure. 4. Schematic of determination of affinity constants by three-step method. Scatchard 
plot and AED calculations are employed to reduce the number of possible adsorption 
isotherm models before the model fitting, and rival models are then compared using the F-
test. 
 
4.9. Molecular dynamics simulation experiments  
MD simulations were performed to gain complementary information on the interactions 
between C6S and selected peptide fragments of apoE and apoB-100. (Papers II, IV) The 
interactions of both systems were studied at physiological temperature 37 ºC,, and then the 
effect of temperature was studied for the C6S–apoB-100 peptide system at 28, 34, 38, 38.5, 
39, 39.5 and 40 ºC. The peptide fragments were assumed to adopt α-helix secondary structure 
and the dodecasaccharide chain of C6S was constructed of six repeating GlcUA β(1→3) 
GalNAc-6-sulfate disaccharides joined by β(1→4) glycoside linkages. [176] Discovery studio 
2.0 [196] was used to model C6S and peptide fragments and to obtain starting conformations 
for C6S–apoE peptide and C6S–apoB-100 peptide systems.  The charge states of C6S, apoE 
peptide, and apoB-100 peptide were chosen to represent the physiological pH, with charges of 
-12, +7, and +6, respectively. The force fields for the peptides were derived from GROMACS 
inbuilt tool pdb2gmx, and a previously designed force field [176] was used for C6S. 
Molecular dynamics simulation packages GROMACS 4.0.5 and 4.0.7, with GROMOS96 
43a2 force field, [197] were applied for the simulations.  
PMF calculation was performed using pull code with constraint distances between C6S and 
peptide center of masses to evaluate the interaction strength of the C6S–peptide systems. 
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Temperature-dependent PMF calculations were carried out at 37 ºC for apoE peptide and at 
28.0, 34.0, 37.0 38.0, 38.5, 39, 39.5, and 40.0 ºC for apoB-100 peptide according to Eq. 23.  
 
4.10. Microscale thermophoresis measurements  
Microscale thermophoresis was employed as complementary technique to determine the 
affinity constants for the apoE2–DS and apoE3–DS systems. (Paper V) The two isoforms and 
DS were diluted in phosphate buffer (pH 7.4, I = 20 mM, tween 0.0025%, v/v) to final 
concentrations of 0.5 µM of each isoform and 40 μM of DS. Since both apoE2 and apoE3 are 
tryptophan proficient, the LabelFree instrument could be used. Dermatan sulfate was used as 
titrant to prepare a dilution series of 16 points (20 µM–0.6 nM). Next, 10 µL of each DS 
solution was mixed with 10 μL of apoE2 or apoE3) and after a short incubation all samples 
were transported to hydrophilic glass capillaries. Capillaries were successively placed inside 
the instrument for the MST measurements performed with Monolith NT.LabelFree. 
Excitation and emission wavelengths of 280 and 360 nm, respectively, were used for 
excitation and detection of the intrinsic UV fluorescence of apoE2 and apoE3. 40% MST 
power and 50% LED power were applied for measurement of the thermophoresis of the 
apoE2–DS complex and, correspondingly, 40% and 40% for the apoE3–DS complex. 
Triplicate measurements were performed for both complexes.   
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5. Results and discussion 
The objective of the work was to develop new biomimicking systems capable of elucidating 
biological interactions. Thus, the first challenge was to develop suitable platforms enabling 
the study of biological interactions under physiological conditions. The second challenge was 
to utilize these platforms in the determination of affinity constants by established analytical 
techniques: QCM, PF-ACE, and CEC. AED calculations were introduced for fuller 
interpretation of QCM and PF-ACE data to allow detection of the heterogeneity of the 
binding processes. Finally, molecular dynamics simulations were employed to visualize 
interactions at the atomic level. 
 
5.1. Development of biomimicking systems  
The development of suitable platforms is vitally important for interaction studies. The 
interactions of interest in this work were ones between carefully selected glycosaminoglycans 
and lipoprotein nanodomains. The studies required either immobilization of one binding 
partner on the chip or capillary surface or the creation of a neutral surface that does not 
interfere with the binding process.  
 
5.1.1. Preparation of glycosaminoglycan-functionalized coated capillary and chip 
surfaces 
The biomimicking systems were first developed for CEC and QCM by coating the capillary 
and chip surfaces with specific glycosaminoglycans. In previous QCM experiments, human 
lipoproteins [24, 25, 27] and collagens [22] were immobilized on the inner surface of fused 
silica capillaries via positively charged amino acid residues, and collagen was immobilized on 
carboxyl chip surfaces via amine coupling. [13] These systems provided a departure point for 
this part of the study. 
 
5.1.1.1. Preparation of heparin-coated capillaries 
Two immobilization methods, involving noncovalent and covalent binding, were employed 
for the attachment of heparin to the fused silica capillary surface, and the effect of the 
immobilization method on the heparin interactions was clarified. The immobilization method 
plays a major role in the determination of interaction strength since, if different functionalities 
are not lost in the noncovalent and covalent coating procedures, the system offers a powerful 
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way to elucidate the effect of specific chemical functionalities on heparin– peptide 
interactions. 
Since the uncoated fused silica capillary surface was negatively charged, the capillary 
surface had first to be modified with APTES to create a positively charged surface for the 
attachment of heparin. The APTES-coated capillary surface gave stable, repeatable (RSD 
3.05%, n = 6) and reverse EOF with DMSO as an EOF marker. 
Ionic interactions between the positively charged amine groups of APTES and the 
negatively charged sulfate and/or carboxyl groups of heparin were utilized in the noncovalent 
immobilization of heparin on APTES-coated capillary. In the covalent coating, EDC linker 
was exploited in the formation of a stable amide bond between carboxyl groups of heparin 
and amine groups of APTES. In this way, the sulfate groups of heparin were left free to 
interact with analytes. 
Before the interaction studies, the coating parameters (incubation time, concentration of 
heparin, and pH of the BGE solution) were optimized for the noncovalent coating. The most 
stable coating, with good reproducibility, was obtained with incubation time of 60 min, 
heparin concentration of 3.0 mg/mL, and BGE pH of 5.5–7.4. The physiological pH 7.4 was 
selected for the further studies, as it is the most relevant pH for interactions between 
lipoproteins and glycosaminoglycans in the onset and progression of atherosclerosis. 
Since long lifetime and stability of the capillary were important not only for practical 
reasons but also to minimize the amount of heparin required, the stability and the capillary-to-
capillary reproducibility of the heparin noncovalent and covalent coatings were evaluated by 
measuring the mobility of the EOF during successive runs at pH 7.4. The EOF mobilities 
were measured for the noncovalent coating at 25 and 37 ºC and for the covalent coating at 37 
ºC on ten successive days (n=6). Between the measurements the capillary was kept filled with 
BGE (pH 7.4). In each case the EOF remained stable over the ten-day period, confirming the 
good stability of the coating.  
Both noncovalent and covalent coating methods demonstrated good repeatability and 
reproducibility (Table 8.) The higher EOF mobilities in the covalently coated heparin 
capillaries demonstrated the presence of a larger number of negatively charged groups relative 
to the capillaries with noncovalently attached heparin. 
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Table 8. Repeatability and reproducibility (n=3) of the EOF in the noncovalently and 
covalently coated heparin capillaries at 25 ºC and 37 ºC.  
 Heparin noncovalent 
coating at 25 ºC 
Heparin noncovalent 
coating at 37 ºC 
Heparin covalent 
coating at 37 ºC 
 EOF 
[10
-8
 m
2
/Vs] 
(RSD%) EOF 
[10
-8
 m
2
/Vs] 
(RSD%) EOF 
[10
-8
 m
2
/Vs] 
(RSD%) 
Capillary 1 5.58 0.4 5.88 4.5 6.16 1.2 
Capillary 2 5.18 3.9 5.95 2.2 6.18 0.6 
Capillary 3 5.40 3.3 5.82 2.4 6.22 1.2 
 
5.1.1.2. Immobilization of glycosaminoglycans on gold-plated chip surface  
Heparin, DS, and C6S were covalently immobilized on the surface of a gold-plated quartz 
crystal chip. The covalent attachment minimized the possible loss of ligand during the 
regeneration step. It was noticed in the CEC studies that the surface of the covalently 
immobilized capillary was stable. 
Heparin was immobilized ex situ on the SiO2 chip via APTES linker under the conditions 
optimized for the immobilization of heparin on the capillary surface. DS and C6S were 
immobilized in situ and the progress of the binding was constantly followed. The coating 
process was finalized when no more ligand attached to the surface.   
The stability of the coating on the QCM chip was evaluated by constantly following the 
regeneration step. When the signal did not return to the baseline the surface was not totally 
regenerated, and when the signal dropped below the baseline the ligand was released from the 
surface. The covalent heparin coating remained stable for one week, after which the binding 
capacity of the surface weakened rapidly as shown by the signal no longer returning to the 
baseline after the regeneration step. Lower frequency shifts and poor repeatability were then 
observed after analyte injection. DS and C6S coatings, in contrast, were stable for several 
weeks. 
Two further immobilization techniques—amine and aldehyde couplings—were exploited 
for the immobilization of C6S on LNB carboxyl surface. Affinity constants were similar for 
the two techniques, showing that both were suitable for the interaction studies.  
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5.1.2. Preparation of neutral capillary surface 
A neutral capillary surface with good hydrophilic properties was needed in the bioseparations 
of model analytes and biomolecular interaction studies carried out by PF-ACE to prevent 
unwanted adsorption of analytes of biological origin. In addition, the capillary surface needed 
to be stable at physiological pH 7.4.  
A number of polymer coatings have recently been developed to meet the need for neutral 
surfaces in CE. Conventional neutral coatings, such as methyl cellulose and polysaccharides, 
often lack stability. [198] Polyethyleneoxide (PEO) coatings reduce EOF by an order of 
magnitude [68, 199] and are more stable than the mentioned neutral polymers, but they are 
easily rinsed out. Various arcylamide coatings have proved successful as neutral coatings. [70, 
200] Test of acrylamide-based PAA coating showed it to provide a fairly neutral surface with 
lifetime up to four days and EOF of 4.5 x 10
-10
 – 6.1 x 10-10 m2/Vs, with RSD% values of 
2.1%, 3.6%, and 4.7% for run-to-run, day-to-day, and capillary-to-capillary, respectively. 
Although the PAA coating successfully prevented the unwanted adsorption, the coating 
procedure was laborious and time consuming. A new block copolymer-based coating was 
accordingly sought, with targets of easy preparation, easy renewal, and good stability at 
physiological pH. 
Block copolymers can combine the properties of materials of very different chemical 
nature, polarity, and size, and they can be exploited for various purposes. Block copolymers 
have been applied to control interfaces between different chemical environments, for instance 
in nanomaterials, drug delivery, and other pharmaceutical applications. [201-203] During the 
last ten years they have been exploited in capillary coatings [155, 204-208] and separation 
media [209-212]. Block copolymer coatings containing the PEO block have reduced EOF to 
as low as +0.1 x 10
-8
 m
2
/Vs and enabled bioseparations. Triblock copolymer coatings without 
binding block have also provided low EOF, but these must be regenerated after each run. 
[213] The amphiphilic block copolymers typically used as coating material have 
disadvantages in the formation of micelles and other self-assembled nanostructures in water 
and a restriction to pH range from 3 to 6. [204]  
The self-assembly problem can be overcome with double-hydrophilic block copolymers 
(DHBC), which are easily synthesized starting from amphiphilic diblock copolymers. [203] 
The two hydrophilic blocks of DHBCs provide lowered surface tension with no tendency to 
form higher-order structures. In this study the amphiphilic block copolymer P2VP-b-PEO was 
quaternized to P2QVP-b-PEO to obtain polymer of polycationic nature with good water 
solubility.  The novel properties of DHBCs make quaternized diblock copolymers promising 
tools for analytical chemistry.  
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5.1.2.1. Characterization of quaternized block copolymer  
The quaternized P2QVP-b-PEO developed in this study was highly hydrophilic and a strong 
polyelectrolyte. (Paper III) It was positively charged and stable in pH range from 1 to 14. The 
first indication of the successful quaternization reaction was the water solubility. Its 
characteristics were evaluated by 
1
H-NMR in CDCl3 and by FTIR, with quaternized 
homopolymer as a reference for the spectral assignment. Quaternized N-methyl was 
confirmed from the 
1
H-NMR spectrum with the signal at δ= ~3.5 ppm and the strong single 
peak of PEO at δ= 3.6 overlapping the N-methyl signal. The signals at δ= 6.9 – 8.5 ppm due 
to pyridine ring confirmed the change in the 2VP/ 2QVP unit.  
The FTIR spectra of the quaternized and unquaternized block copolymer were compared to 
identify N-methyl absorptions. Unmodified pyridine presented the absorption at 1590 cm
-1
, 
and the quaternized pyridine ring showed absorptions at 1627–1629 cm-1 and 1512–1513 cm-
1
. Comparison of the quaternized and unquaternized homopolymer also provided the N-
methyl absorption at 1627 or 1629 cm
-1
. The degree of quaternization (~80%) was evaluated 
using peak 1341 cm
-1
 as internal standard, since it remained unchanged during the 
quaternization.  
 
5.1.2.2. P2QVP-b-PEO coating  
Quaternized P2QVP-b-PEO diblock copolymer was employed as a coating material to 
suppress EOF and prevent the adsorption of positively charged analytes. (Papers III, IV, V) 
The positive block (P2QVP) of the quaternized P2QVP-b-PEO was bound strongly to the 
negatively charged capillary wall, while the neutral hydrophilic group (PEO) stabilized the 
system and formed the neutral surface. The effective shield created by P2QVP-b-PEO 
successfully suppressed the EOF (+2.0–+4.5 x 10-10 m2/Vs) at pH 7.4.  
P2QVP-b-PEO combined the advantages of a covalent coating, such as PAA, and the easy 
preparation of a dynamic coating. The steric structure of the vinylpyridinium ring (positive 
charge located in 2-position of the amine functionality) provides an effective shield for 
deprotonated silanol groups of the capillary inner wall, while the PEO block is oriented 
toward the center of the capillary (Figure 5). The orientation of the capillary coating was 
confirmed by AFM images of the uncoated (Figure 6A) and coated (Figure 6B) surfaces.  
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Figure 5. Proposed model for the P2QVP-b-PEO coating. 
 
 
Figure 6. AFM images of A) unmodified and B) P2QVP-b-PEO coated fused silica capillary 
surface. 
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5.1.2.3. Optimization of the coating parameters  
The coating conditions were optimized for pH, flushing time, and the concentration of diblock 
copolymer solution by measuring the EOF by the method of Williams and Vigh [193]. (Paper 
III) DMSO was used as EOF marker. All pH values, the three flushing times, and the four 
P2QVP-b-PEO concentrations that were studied provided suppressed EOF (Table 9). The pH 
value 7.4, flushing time of 40 min, and concentration of 0.1 mg/mL were selected for the 
further studies to ensure physiological conditions, fast preparation of the capillary, and  the 
lowest possible consumption of P2QVP-b-PEO.   
 
Table 9. Optimization of the coating parameters in terms of pH, flushing time of the capillary 
with P2QVP-b-PEO solution, and concentration of P2QVP-b-PEO.  
pH 5.5 6.5 7.4 
EOF [10
-10
 m
2
/Vs] +7.7 +2.3 +2.0 
Flushing time [min] 20 40 60 
EOF [10
-10
 m
2
/Vs] +3.2 +2.0 +2.3 
Concentration of P2QVP-b-PEO 
[mg/mL] 
0.05 0.1 0.2 0.5 
EOF [10
-10
 m
2
/Vs] 7.8 2.2 1.0 0.67 
 
Whenever the EOF increased and the run-to-run repeatability deteriorated, the coating 
could easily and quickly be renewed by flushing the capillary with BGE (1 bar) for 20 to 30 
min between runs. The lifetime of the capillary could be lengthened in this way, since 
flushing restored the properties to those of the freshly coated capillary. The flushing probably 
resolved the collapsed PEO chains, thereby providing better stability.  
 
5.1.2.4.  Stability and reproducibility of the P2QVP-b-PEO coating  
Good stability over a range of pH values widens the applicability of the capillary in 
separations and interaction studies. Stability at physiological pH, which is particularly 
important in biomimicking studies, has been one of the shortcomings of dynamic polymer 
coatings. [68] EOF was suppressed at all pH values studied, and the capillary remained stable 
for eight days. After 15 days the EOF was significantly increased (Table 10). The capillary-
to-capillary reproducibility gave EOF values from +2.0 x 10
-10
 m
2
/Vs to +4.5 x 10
-10
 m
2
/Vs 
(RSDs 1.3%–7.6%) for five different capillaries. (Paper III) 
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Table 10. Lifetime and pH stability of the P2QVP-b-PEO coated capillary.  
Lifetime [day] 1 2 3 4 5 8 15 22 
EOF [10
-10
 m
2
/Vs] 1.2 3.1 2.8 4.7 5.8 3.1 54 18 
pH 4.0 4.5 5.5 6.5 7.4 8.5 9.5 10.5 
EOF [10
-10
 m
2
/Vs] -1.6 0.40 1.4 4.2 2.2 3.8 4.9 2.8 
 
The facility to regenerate or recoat the capillary is a huge advantage as costs will be 
lowered accordingly. Because the P2QVP-b-PEO coating was not covalently attached to the 
capillary surface, it could be removed by flushing the capillary with 1 M HCl. The inner 
surface of the capillary could then easily be recoated to provide once again ultra-low EOF. 
Regeneration of the coating without removing the remaining coating could be achieved 
simply by flushing the capillary with block copolymer solution for 20 min. Low EOF values 
of +1.9 x 10
-10
 m
2
/Vs (n=3, RSD 6.8 %) and +2.8 x 10
-10
 m
2
/Vs (n=3, RSD 7.7 %) were 
obtained after regeneration with and without removal of the coating.  
 
5.1.2.5. Separation of beta-blockers, basic proteins, and lipoproteins.  
Good stability of the coating is not sufficient if the coating does not allow bioseparations of 
complex samples. Possible biofouling of the capillary during coating was investigated with 
three groups of analytes (beta-blockers, basic proteins, and lipoproteins) with different molar 
mass ranges. (Paper III) Coating is required for successful separation of all these analytes. 
[26, 214, 215]  Baseline separation is essential for the reliable identification and quantification 
of beta-blockers, which are prohibited drugs in sports. [216] Chemical separations of cationic 
proteins are challenging because the separation will fail if the proteins interact with the bare 
silica [215]. Large lipoproteins, were of interest here because non-absorption is an important 
requirement for interaction studies carried out by PF-ACE. Like the cationic proteins 
investigated, lipoproteins would adsorb strongly on the negatively charged uncoated capillary 
wall [26] via regions containing positively charged amino acids.  
The separation conditions were optimized for each set of analytes. The most effective 
separation for the mixture of five beta-blockers (metoprolol, atenolol, propranolol, pindolol, 
and alprenolol) at four pH values (4.5, 5.5, 6.5, and 7.4) was obtained with the help of 
stacking by conductivity effect: beta-blockers were diluted into 10 mM buffer and 70 mM 
buffer was used as BGE. Next, the pH (4.0, 5.5, 6.5, 7.4) and ionic strength were optimized 
for the separation of basic proteins cytochrome C, lyzosyme, and α-chymotrypsinogen, and 
the best separation was achieved at pH 4.0, I = 20 mM. The recoveries [217] of the basic 
proteins obtained under these conditions (Table 11) demonstrate that the quaternized block 
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copolymer coating, P2QVP-b-PEO, effectively prevents adsorption of the proteins on the 
capillary wall.   
 
Table 11. RSD values (n=3) of the migration times, plate numbers, and recoveries of the 
basic proteins at pH 4 (I =20 mM). 
 tm N Recovery 
 (RSD%) (1/m) (%) 
Cytochrome C 0.096 320000 97 
Lysozyme 0.11 213000 93 
α-Chymotrypsinogen A 0.093 229000 99 
 
The separation efficiency was then evaluated for basic proteins and beta-blockers in terms 
of plate numbers (1/m) and repeatability of the migration time. The values obtained (Tables 
11 and 12) demonstrate highly repeatable and efficient separations. They are also in good 
agreement with previously reported efficiencies. [214, 218] Lower pH values (4.5 and 5.5) 
gave the lowest RSD values and highest plate numbers for the beta blockers, which 
demonstrates that the coating was also the most stable at these pH values.   
 
Table 12. RSD values (n=3) of the migration times and plate numbers for the separation of 
beta-blockers. Pindolol (pKa 8.8), alprenolol (pKa 9.4), propranolol (pKa 9.5), atenolol (pKa 
9.4), metoprolol (pKa 9.5). 
Beta-bloker  
pH 7.4 pH 6.5 pH 5.5 pH 4.5 
tm N tm N tm N tm N 
(RSD%) (1/m) (RSD%) (1/m) (RSD%) (1/m) (RSD%) (1/m) 
Pindolol  0.19 353000 0.060 337000 0.12 700000 0.034 250000 
Alprenolol  0.18 250000 0.071 407000 0.047 612000 0.033 617000 
Propranolol  0.20 240000 0.076 280000 0.059 463000 0.025 453000 
Atenolol 0.20 477000 0.043 533000 0.048 607000 0.058 630000 
Metoprolol 0.19 350000 0.064 357000 0.051 517000 0.011 603000 
 
The strong adsorption of lipoproteins onto the negatively charged capillary wall is due to 
the large number of positive charges and heterogeneity of the lipoproteins. [26, 214] The 
P2QVP-b-PEO coating enabled the successful and repeatable baseline separation of 
lipoproteins LDL (pI 5.5), VLDL (pI 4.7-4.8), and HDL3 (pI 5.0) (Figure 7) under 
physiological conditions (pH 7.4, I = 20 mM, T = 25/37 ºC), demonstrating the suitability of 
this coating for biomimicking studies. The separation of lipoproteins was repeated three 
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times, and RSD values of migration times were 0.42%, 1.7%, and 1.5% at 25 ºC and 0.25%, 
0.075%, and 5.0% at 37 ºC for VLDL, HDL3, and LDL, respectively. 
The results showed that the P2QVP-b-PEO coated capillary can provide efficient and 
repeatable separation of beta-blockers and cationic proteins and offers great potential for 
studies on lipoprotein interactions. The P2QVP-b-PEO coating provided EOF values of the 
same magnitude as the PAA coating but preparation time was much shorter. P2QVP-b-PEO is 
thus a promising coating material for many separations of a biological nature. 
Figure 7. The separation of lipoproteins (1) VLDL, (2) HDL3, and (3) LDL on P2QVP-b-PEO 
coated capillary. Running conditions: Ltot 38.5 cm, Ldet 30 cm; detection at 200 nm; voltage 
+25 kV; temperature 25 ºC; injection time 1 s at 50 mbar; BGE phosphate buffer pH 7.4 
(I=20 mM); concentration of lipoproteins 0.05 mg/mL (VLDL), 0.2 mg/mL (HDL3), and 0.1 
mg/mL (LDL) in 20 mM phosphate buffer (pH 7.4). 
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5.2. Biomimicking interaction studies 
Interactions between glycosaminoglycans and lipoproteins play an important role in the 
development of atherosclerosis, and several analytical techniques have been applied to further 
our understanding of the process. QCM and various capillary migration techniques have 
proved useful in studies of the interactions between nanodomains of biological importance 
and have been successfully exploited in glycosaminoglycan–lipoprotein investigations. [6, 13, 
21, 22, 24-28, 57, 218] Since CEC has demonstrated great flexibility and potential for the 
elucidation of biological interactions, [22, 23, 25] it was selected as the first method for 
investigation. By assisting the interpretation of adsorption data, AED calculations have 
recently widened the applicability of liquid chromatography and SPR from one-site 
interaction studies to heterogeneous interaction studies. [76, 77, 172, 219] Study was also 
made of the feasibility of applying AED calculations in the data processing step in QCM and 
PF-ACE, and in that way extending their use in fundamental interaction studies. For 
comparison and confirmation of the results, a relatively new technique, microscale 
thermophoresis, was employed for study of DS–apoE binding constants. Furthermore, 
molecular dynamics simulation methods were included as a complementary approach to 
provide results at the atomic and molecular level that are difficult or even impossible to obtain 
experimentally.  
  
5.2.1. Heparin interactions 
Heparin is a highly sulfated glycosaminoglycan, which retains lipoproteins strongly. 
Apolipoproteins B-100 and E both contain several heparin binding sites, through which the 
interaction primarily occurs. [117, 118] Peptide fragments of apoB-100 and apoE which 
contain a large number of positively charged arginine and lysine groups were investigated, 
along with LDL and HDL. The affinity of the peptide fragments was studied in terms of 
affinity constants and retention factors, and the affinity of HDL and LDL in terms of reduced 
mobilities. The role of apoE in the binding of HDL to heparin was clarified.  
The interactions were evaluated by two complementary techniques, QCM and OT-CEC. In 
both cases heparin was immobilized on the silica surface via APTES linker. The affinity 
constants for interactions between heparin and apoB-100 peptide and heparin and apoE 
peptide were obtained by QCM at 25 and 37 ºC by using Scatchard plot analysis. The log Ka 
values obtained for the apoB-100 and apoE peptides were 5.54 and 5.20 at 25 ºC and 5.22 and 
5.02 at 37 ºC, respectively. The affinities of heparin for the apoE peptide are slightly lower 
but in good agreement with the log Ka values reported by Futamura et al. [120]: 5.59 for the 
Mr 22 000 peptide fragment of apoE3, 5.80 for the Mr 10 000 peptide fragment of apoE, and 
7.66 for apoE. The lower values of the present study were probably due to the shorter 
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molecule that was used here and the differences in the heparin immobilization technique. 
[120]  
The affinity between heparin and peptide fragments of apoB-100 and apoE was also 
analyzed by OT-CEC in terms of retention factors (Eq. 4). The affinity of apoB-100 peptide 
for covalently bound heparin was about twice as strong as the affinity for noncovalently 
bound heparin, whereas the affinity of apoE peptide for heparin was at the same level whether 
heparin was noncovalently or covalently attached to the capillary surface (Table 13). 
Surprisingly, both OT-CEC and QCM demonstrated slightly stronger interaction between 
covalently bound heparin and apoB-100 peptide than between heparin and apoE at 
physiological temperature (37 ºC). 
The covalent attachment of heparin to APTES takes place through the carboxyl groups and 
leaves the sulfate groups available for interaction. However, when heparin is noncovalently 
attached to APTES, both carboxyl and sulfate groups take part in the electrostatic interaction 
between heparin and APTES, leaving fewer free sulfate and more carboxyl groups available 
for heparin interactions.  The strong affinity of apoB-100 peptide for covalently bound 
heparin suggests that sulfate groups play a more important role than carboxyl groups in the 
interaction between heparin and apoB-100 peptide. The affinity of apoE peptide for heparin 
was seemingly not affected by the immobilization method, which suggests that apoE interacts 
with both carboxyl and sulfate groups.  
The interactions of heparin with lipoproteins were clarified by OT-CEC in terms of 
reduced mobilities (Eq. 5). [170] The role of apoE in the binding processes was evaluated by 
studying the interactions of heparin, under physiological conditions (pH 7.4 and 37 ºC), with 
HDL with and without apoE and with the isolated apoE, and finally the results were compared 
with those for LDL.  
From Table 13 we can see that HDL and apoE interact more strongly with the heparin-
coated capillaries than with the uncoated capillary, whereas HDL without apoE has almost the 
same reduced mobilities in the three capillaries. Since the affinity for heparin in the covalently 
coated capillary decreased in the order apoE-containing HDL > apoE > HDL without apoE, 
we can conclude that apoE has an essential role in the interactions between HDL and heparin. 
The results are in good agreement with those obtained in earlier studies. [125] Multiple 
binding sites in HDL or a more favorable lipid-induced conformation of apoE on HDL may 
be responsible for the stronger affinity of heparin for apoE when apoE is on the HDL particle 
surface than when it is floating freely in solution.[113] 
Finally, study was made of the affinity of heparin for LDL. In the interaction between 
heparin and apoB-100 peptide, the sulfate groups played a more important role than the 
carboxyl groups. The same clear trend was seen for heparin and LDL. The reduced mobility 
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of LDL in noncovalently coated heparin capillaries, where both carboxyl and sulfate groups 
were employed in the immobilization of heparin on the APTES surface, was about one-half 
that in covalently attached heparin capillaries, where sulfate groups were freely available for 
interaction. The affinity of LDL for the covalently attached heparin was clearly stronger than 
that of apoE or HDL. In the case of noncovalent coating, the affinity was about the same for 
all three biomolecules. These results clearly demonstrate the importance of the selected 
peptide fragments of apoB-100 and apoE in the interactions. Furthermore, it was 
demonstrated that the peptide fragments, although simplified nanodomains of LDL and of 
HDL with apoE, can successfully be used in studies of lipoprotein behavior. 
 
Table 13. Affinity constants, retention factors, and reduced mobilities for interactions 
between heparin and selected lipoprotein particles. 
 Affinity constant log Ka Retention factor 
 25 ºC 37 ºC Covalent 
coating 
Noncovalent 
coating 
ApoB-100 peptide 5.54 5.22 0.64 0.33 
ApoE peptide 5.20 5.02 0.62 0.61 
 Reduced mobility 
 Covalent coating Noncovalent coating Uncoated capillary 
ApoE -1.07 -0.78 -0.70 
HDL -1.16 -1.20 -0.78 
HDL (no apoE) -0.94 -0.97 -0.95 
LDL -1.79 -1.04 -0.68 
 
5.2.2. Chondroitin-6-sulfate interactions 
Among the proteoglycans of extracellular matrix components, chondroitin-6-sulfate has been 
recognized to play a particularly important role in the interaction with certain apoB-100 
regions of LDL and in that way to affect the development of atherosclerotic diseases. [220] 
C6S is characterized by repetitive, sulfated disaccharide units, and the combination of 
carboxyl and sulfate groups makes each repeat unit highly negative. As in the case of heparin, 
the negatively charged groups of C6S have strong electrostatic interactions with the positively 
charged basic amino acids, such as arginine and lysine, in apoB-100.  
Two instrumental techniques, QCM and PF-ACE, were employed for elucidation of the 
C6S interactions with apoE peptide, apoB-100 peptide, and LDL. AED calculations were 
employed to study the heterogeneity of the binding processes in detail, and molecular 
dynamics simulations completed the studies. After ensuring the practical value of these three 
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different approaches in interaction studies, an answer was sought to the specific question, 
“Does temperature contribute to the progression of atherosclerosis by affecting the interaction 
of LDL with arterial C6S?” 
  
5.2.2.1. Chondroitin-6-sulfate – apoB-100 peptide interaction studied by QCM and AED 
calculations    
In continuous flow QCM studies employed for clarification of the affinity constant for the 
C6S–apoB-100 peptide system at 25 ºC and 37 ºC, C6S was covalently attached to a LNB 
carboxyl chip surface via amine coupling to avoid losses of functional sulfate and carboxyl 
groups. Fifteen different concentrations (5-100 µg/mL) were used to obtain sufficient 
adsorption data for the binding study. As expected, the peptide fragment containing positively 
charged lysine and arginine residues interacted strongly with C6S, presumably mostly via 
electrostatic interactions. 
AED calculations comprising the three steps described in section 4.8 were exploited for 
determination of the affinity constant and to distinguish between unimodal and multimodal 
adsorption models. The linear Scatchard plots (Figure 8) obtained at 25 ºC and 37 ºC strongly 
indicated single-site interaction, and AED calculations supported this observation since 
unimodal binding processes were observed at both temperatures (Figure 8C).  Affinity 
constants were determined from the position of the apex on the x-axis, while the monolayer 
saturation capacity (Δfmax) was determined as the area of the distribution coefficients. As can 
be seen in Table 14, the log Ka values obtained by the AED calculations and Langmuir model 
fitting were similar, with no effect of temperature. The main difference at the two 
temperatures was the monolayer saturation capacity, which was smaller at 37.0 ºC than at 
25.0 ºC.  
 
Table 14. Affinity constants estimated from adsorption energy distribution calculations and 
Langmuir model fitting for C6S–apoB-100 peptide. 
 AED Model fit 
Temperature 
[ºC] 
Δfmax [Hz] log Ka Δfmax [Hz] log Ka RSD% 
(n=3) 
25 5.67 4.62 5.54 4.65 6.8 
37 2.43 4.64 2.39 4.66 24.7 
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Figure 8. A) Adsorption isotherm, B) the corresponding Scatchard plot, and C) AED 
calculation of apoB-100 peptide–C6S interaction at 25 ºC and 37 ºC. 
 
5.2.2.2. Chondroitin-6-sulfate – apoB-100 peptide interaction studied by PF-ACE 
The strength of the C6S–apoB-100 peptide interaction was studied by PF-ACE under 
physiological conditions first by testing different C6S filling times (from 5 to 40 s) and 
concentrations (from 0.001 to 1.0 mg/mL). The highest C6S concentration (1.0 mg/mL) was 
selected to maximize the UV absorbance. Since filling times longer than 30 s resulted in band 
broadening, the smaller filling times were selected for further studies. The corrected change in 
the migration time was found to increase linearly (correlation coefficient 0.998) with the 
filling time of C6S. The affinity constant log Ka value of 5.02 with RSD of 1.45% (n = 3) at 
37 ºC was determined according to Eq.10. The affinity constants for the C6S–apoB-100 
peptide system determined by PF-ACE and QCM agree quite well given the differences in the 
techniques: in PF-ACE both C6S and apoE peptide are moving freely, whereas in QCM the 
C6S is immobilized on the chip surface. Moreover, the values obtained are well aligned with 
those reported earlier for the apoB-100 sequence 3359–3377 linked to lipid vesicles. [145] 
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5.2.2.3. Temperature dependence of C6S – apoB-100 peptide interaction studied by 
QCM  
The work was continued with a closer evaluation of the effect of temperature on the 
interaction. C6S was now attached on the LNB surface via aldehyde coupling and, differing 
from the earlier experimental set-up (section 5.2.2.1.), adjustment of physiological pH 7.4 was 
done with PBS instead of with phosphate buffer containing NaCl. The use of a larger amount 
of salt was found to accentuate the difference in results at the two temperatures, 25 °C and 37 
°C. 
AED calculations were performed, with the three-step approach, for the determination of 
affinity constants at seven temperatures: 25.0, 28.0, 34.0, 37.0, 38.0, 39.0, and 40.0 ºC. The 
experimental noise was reduced by analyzing each concentration point three times. As 
displayed in Figure 9 a and b, the adsorption isotherms were convex upward over the whole 
temperature range investigated. The AED plots showed only one distribution at temperatures 
between 25.0 and 39.0 ºC, and the Scatchard plots were linear in the same range. At  40.0 ºC , 
however, two distributions appeared in the AED plot (Figure 9c) and the Scatchard plot was 
nonlinear.  
As can be seen in Figure 10, the affinity constant is strongly temperature dependent. The 
adsorption energy decreases with increasing temperature down to a minimum at 38.0 ºC and 
thereafter starts to increase. The temperature dependency was evaluated as change in the 
interaction enthalpy (ΔH) by a van’t Hoff plot and as change in the heat capacity (ΔCp) by a 
Gibbs–Helmholtz plot, where ΔG was displayed as a function of temperature. Nonlinear 
behavior of the van’t Hoff plot suggests structural changes of solute or adsorbent, and the 
concave down Gibbs–Helmholtz plot indicates a positive ΔCp for the binding of apoB-100 
peptide with C6S. The adsorption energy of -52.4 kJ/mol in the temperature range from 25.0 
to 38.0 ºC suggested that the interactions are mainly caused by the noncovalent binding via 
electrostatic interaction. An average adsorption energy of 53 kJ/mol was obtained at 39.0 and 
40.0 ºC by using the Arrhenius equation and assuming a constant pre-exponential factor. 
These results indicate that the adsorption process is exothermic up to approximately 38.0 ºC 
and thereafter becomes endothermic. The heat production is thus favorable at higher 
temperature, accelerating the interaction. Interestingly, these changes occur in the temperature 
region where the interaction becomes heterogeneous. At 40.0 ºC the AED calculations 
demonstrated heterogeneous interaction with affinity constants (log Ka) of 4.8 and 3.4.  
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Figure 9. Adsorption isotherm for A) low and B) high concentration range and C) 
corresponding AED calculation for apoB-100 peptide at 25.0, 28.0, 34.0, 37.0, 38.0, 39.0, 
and 40.0 ºC. The bimodal distribution at 40 ºC is shown in the inset.  
 
5.2.2.4. Temperature dependence of C6S – apoB-100 peptide interaction studied by 
molecular dynamics simulations 
MD simulations were used as complementary technique in the temperature studies. The 
strength of the interaction was evaluated in terms of affinity constants obtained with a free 
energy calculation performed through PMF calculation (Eq. 23) using an MD simulations 
tool. The interaction was studied around  physiological temperature, at 25.0, 28.0, 34.0, 37.0, 
38.0, 38.5, 39.0, 39.5, and 40.0 ºC.  
The temperature behavior of the affinity constants revealed in the MD simulations was 
similar to that observed in the QCM experiments. The affinity constant was more or less 
constant from 25.0 to 37.0 ºC but became nonlinear above 37.0 ºC (Figure 10). A detailed 
study of the contributions affecting these temperature-dependent interactions was carried out. 
The visualization at the minimum of PMF showed the contribution of the salt to the 
interactions, while the separated minima observed at 40.0 ºC were attributable to H-bonded 
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water bridging the apoB-100 peptide and C6S. Large structural changes were also detected at 
38.0, 39.0, and 39.5 ºC, and three salt bridges observed at the highest point (39.5 ºC) 
demonstrated that lysine groups favor carboxyl groups, whereas arginine groups prefer sulfate 
groups. These results were in good agreement with the temperatures at which the largest 
minima occur in the PMF. 
 
 
Figure 10. Temperature trends for C6S – LDL and C6S–apoB-100 peptide interaction 
obtained by QCM, PF-ACE, and MD simulations. 
 
The log Ka values obtained from MD simulations (6.3-8.4) were significantly higher than 
those obtained by QCM and PF-ACE, probably because of the longer relaxation time, which 
allowed more time for molecules to interact. Also relevant may be the starting helical 
structure for the peptide of apoB-100, which favors maximum salt bridge formation, [221] 
and the concentration effect, which causes a steric secondary or/and tertiary structure of 
peptide of apoB-100 in solution.  
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5.2.2.5. Temperature dependence of the C6S - LDL interaction 
The next step was to clarify whether the temperature-dependent trend observed for the C6S–
apoB-100 peptide interaction also appears in the C6S–LDL system. The study, carried out by 
QCM and PF-ACE, was focused on the most interesting temperatures (37.0, 38.0, 39.0, and 
40.0 ºC), where the behavior of the C6S–apoB-100 peptide system was nonlinear. 
Determination of the log Ka values by QCM was here carried out by estimating the 
adsorption and desorption rate constants kon and koff, respectively, according to Eq. 1. 
Nonlinear behavior with considerable decrease in affinity was observed from 37.0 to 38.0 ºC. 
The affinity increased between 38.0 and 39.0 ºC and then decreased again to 40 ºC. The 
obtained log Ka values ranged from 10.1 to 11.0 (RSD 37%–54%). Perhaps the hydrophobic 
chains of the 11-MUA linker between the gold plate and C6S strengthened the observed 
interaction or caused unspecific binding, resulting in the slightly higher log Ka values than 
found in previous studies. [113] Reasons for the noisy data, causing the large deviations, 
could be the changes in viscosity around the physiological temperature.  
PF–ACE was brought in to verify the nonlinear trend of the affinity constant as a function 
of temperature revealed by QCM. The P2QVP-b-PEO coated capillary was partially filled 
LDL, after which C6S was injected for 1, 2, 3, 4, 5, and 6 s. Since both C6S and LDL have 
negative net charge at pH 7.4, they both move toward the detector at the anode end. With its 
higher mobility, C6S overtakes LDL and forms a complex with it. As can be seen in Figure 
11, the migration time of the C6S–LDL complex decreases linearly as a function of the 
amount of C6S injected. At the same time, the peak height of the free C6S increases, 
demonstrating an excess of C6S. The affinity constants (log Ka) determined by Eq. 10 showed 
a nonlinear trend with values in the range of 8.69–8.91 (Figure 10).  
The peculiar temperature dependency revealed by QCM and PF-ACE was similar for C6S–
apoB-100 peptide and C6S––LDL systems. Computational approaches supported the results, 
and in each case there was a significant increase in affinity above 38.0 ºC, as demonstrated in 
Figure 10. These observations raise new questions, in regard to the roles of 
glycosaminoglycans and temperature increase in the development of atherosclerosis.    
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Figure 11.  Electropherograms obtained by PF-ACE measurements at 37.0 ºC displaying the 
migration time variation of the C6S–LDL complex as a function of filling time of C6S (1, 2, 3, 
4, 5, and 6 s) in P2QVP-b-PEO coated capillary. Running conditions: Ltot 38.5 cm, Ldet 30 cm, 
voltage -25 kV, LDL injection for 2 s at 50 mbar, det. 200 nm, LDL solution (0.1 mg/mL),  
C6S solution (0.6 mg/mL), BGE: phosphate buffer (pH 7.4, I = 20 mM). 
 
5.2.2.6. Chondroitin-6-sulfate and apoE peptide interactions 
The apoE peptide fragment of HDL has a fairly similar structure (though fewer amino acids) 
and charge distribution to the widely studied apoB-100 peptide. In this part of the study, 
methods developed for the C6S–apoB-100 peptide were applied in the study of C6S–apoE 
peptide interactions. First the heterogeneity of the binding was investigated by QCM with 
AED calculations. The measurements were carried out at 25 and 37 ºC with 20 mM phosphate 
buffer (pH 7.4, containing 25 mM NaCl). The three-step method (sect. 4.8) was employed in 
the determination of affinity constants. The Scatchard plots obtained for the interaction 
indicated heterogeneous behavior (Figure 12), and AED calculations revealed (Figure 12C) at 
least one unconverted low energy site (log Ka 3.91 and 3.90 at 25 ºC and 37 ºC, respectively) 
and one converted high energy site (log Ka 5.42 and 5.21 at 25 ºC and 37 ºC, respectively). 
Unconverted sites have frequently been observed [145, 146] because the concentration points 
selected are not always high enough adequately to cover the low binding adsorption sites. 
According to the AED plot (Figure 12C), the low energy site is not affected by the 
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temperature change, whereas the high energy site shows exothermic behavior, similar to that 
observed for the C6S–apoB-100 system below 38.0 ºC.   
In PF-ACE studies the PAA-coated capillary was first filled with positively charged apoE 
peptide, and then negatively charged C6S was injected.  The concentrations (1.0 mg/mL for 
C6S and 0.01 mg/mL for apoE peptide) and filling times (10, 15, 20, 25, and 30 s for C6S and 
5 s for apoE peptide) were those optimized for the C6S–apoB-100 peptide system. The 
affinity constant, determined according to Eq. 10 with use of the EOF-corrected changes in 
the migration times, was 5.28 with RSD 1.87% (n = 3).  
The third approach, molecular dynamics simulations, was again employed to complement 
the QCM and PC-ACE studies. A free energy calculation was performed through PMF 
calculation using the MD simulations tool. The log Ka value of 4.60 agreed well with the 
values obtained by QCM and PF-ACE.  
 
 
Figure 12. A) Adsorption isotherm, B) corresponding Scatchard plot, and C) AED calculation 
of C6S – apoE peptide interaction at 25 ºC and 37 ºC. 
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5.2.3. Dermatan sulfate interactions 
DS, which like C6S has been associated with cardiovascular diseases, was selected as the 
final target glycosaminoglycan. The IdoA in its structure gives it similarities with heparin. 
IdoA also makes the structure of DS more flexible than that of C6S and allows specific 
interaction with proteins and polysaccharides.  Since the fraction of HDL particles containing 
positively charged apoE domains mediates the binding of HDL to GAGs, similarly to apoB-
100 of LDL, apoE peptide was selected for the study.   
The successful application of AED calculations to the interpretation of QCM results 
encouraged us to apply  AED calculations to PF-ACE. The power of AED calculations to 
reveal weaker binding sites and extract more information from the PF-ACE results was tested 
in interactions studies of two different isoforms of apoE with dermatan sulfate. MST and 
QCM combined with AED calculations were used as supporting techniques.  
P2QVP-b-PEO coated capillaries were partially filled with constant concentration and 
volume of apoE (inj. 1 s 50 mbar), after which DS was injected (inj. 2-3 s 50 mbar) at 
different concentrations (2 μg/mL – 800 μg/mL). Both DS and apoE were negatively charged 
and, after the voltage was applied, they began to migrate toward the detector located at the 
anode end. The difference in the mobilites of apoE and DS enabled them to interact when DS 
overtook the slower moving apoE. The migration time of the excess DS remained constant, 
while the migration time of the apoE–DS complex decreased as a function of the increased 
amount of DS (Figure 13). The resulting migration times of the complex were corrected with 
EOF measured between the runs.  
The AED calculations revealed significant differences in the DS interactions with the two 
isoforms of apoE. As can be seen in Figures 14 and 15, binding is unimolar in the apoE2–DS 
system and multimolar in the apoE3–DS system. The affinity constants determined as log Ka 
values were 6.1 for the one-site binding of apoE2–DS and 5.9 and 4.8 for the two-site binding 
of apoE3–DS. The results confirm that coupling of AED calculations with traditional 
analytical techniques can provide good visualization of even small changes in the binding 
process. The difference in affinity for the two isoforms of apoE is explained by the difference 
in the 158
th
 amino acid, which was cysteine in apoE2 and arginine in apoE3. Cysteine can 
form disulfide bonds with other cysteine molecules thereby affecting the secondary and 
tertiary structures. The mutation from cysteine to arginine may have caused significant 
structural changes in the apoE, and the second binding site may then have become more 
available for the interaction. The arginine group would also increase the affinity since it 
interacts with negatively charged glycosaminoglycans.    
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Figure 13. Electropherograms demonstrating interactions between apoE3 and dermatan 
sulfate at 25 ºC. Ltot/ Ldet 38.5/30 cm, i.d. 50 μm;  det. 200 nm; voltage -20 kV; BGE: 
phosphate buffer pH 7.4 (I= 20 mM). Complex peaks illustrate the shift in migration times as 
a function of DS concentration. 
 
 
Figure 14. A) Adsorption isotherm, B) Scatchard plot, and C) AED calculation for the 
apoE2–DS system at 25 ºC with PF-ACE. 
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Before the AED calculations, the amount of adsorbed fraction of apoE was determined for 
each complex according to Eq. 15. The maximum and minimum mobilities needed for the 
calculation were determined with nonlinear fitting over the whole range and linear fitting over 
the linear range.  
 
Figure 15. A) Adsorption isotherm, B) Scatchard plot, and C) AED calculation for the apo3–
DS system at 25 ºC with PF-ACE. 
 
Microscale thermophoresis was employed as a comparative and supportive technique for 
the apoE–DS systems studied by PF-ACE. Both isoforms of apoE are tryptophan proficient, 
and the measurements were carried out with a LabelFree instrument at ambient temperature 
and, to avoid unwanted adsorption, in hydrophilic capillaries (i.d. 100 μm). Concentration of 
the apoE isoforms was constant during the measurements, whereas the concentration of DS, 
used as titrant, was varied between 0.6 nM and 20 µM. Thermophoretic movement after the 
heating with IR laser was reflected as a change in the fluorescence, which was measured, first 
in the initial state and then after 30 seconds heating with the laser, for 16 concentration points. 
Measurement times could be short because mass diffusion over the small dimension of the 
temperature distribution is fast. 
Affinity constants were determined by plotting normalized fluorescence as a function of 
concentration (Figure 16) and then solving for Kd by Eq. 19. The log Ka-values of 6.60 for the 
apoE2–DS and 6.61 for the apoE3–DS system agreed well with values obtained by PF-ACE 
69 
 
with AED calculations. PF-ACE and MST are suitable complementary techniques since, in 
both, analytes float freely in the capillary and none of the functional groups are lost during the 
covalent attachment on the chip surface or in the labeling process. If higher concentrations 
can be used, MST also allows determination of the heterogeneity of the binding. 
 
Figure 16. Illustration of MST data for A) apoE2–DS and B) apoE3–DS systems 
 
Lastly, the affinity constant for the DS–apoE peptide system was determined by QCM with 
AED calculations. The three-step method was applied. Scatchard plot analysis demonstrated 
nonlinear behavior, and two peaks appeared in the AED plot indicating two-site interaction. 
The log Ka values determined from the AED calculations were 5.1 and 1.0 for the first and 
second binding sites, respectively.  
In terms of affinity constants, the results obtained for the DS–apoE and DS–apoE peptide 
systems by different techniques were in good agreement. The secondary binding detected for 
apoE peptide but not for apoE2 might be due to structural changes occurring during the 
interaction. Perhaps the apoE peptide can undergo changes in its secondary structure that do 
not occur for the whole protein.  
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5.3. Comparison of techniques 
The primary experimental techniques used for the determination of biological interaction 
strengths were QCM, PF-ACE, and OT-CEC. All three demonstrated good potential for the 
study of biomolecular interactions. Features important for interaction studies are compared in 
Table 15.  
QCM and PF-ACE allow the determination of affinity constants, while in OT-CEC the 
interaction strength is usually determined in terms of retention factors. Affinity constants 
allow a more reliable comparison of techniques. 
PF-ACE and OT-CEC offer faster analysis times than QCM when the binding affinity is 
determined by steady state or kinetic analysis. Although the use of AED calculations in the 
interpretation of QCM and PF-ACE data increases analysis times markedly because of the 
large number of concentration points needed, both techniques are then able to provide 
information on heterogeneous interactions. The measurement of heterogeneous interactions 
also requires larger sample volumes than in traditional approaches. In fact, weaker binding 
sites cannot be detected at all with traditional approaches. Since high concentrations and large 
number of concentration points are needed in any study of heterogeneous interactions, 
independently of the experimental method, it is sample consumption that becomes the critical 
factor. This being the case, the smaller sample volumes and shorter analysis times of PF-ACE 
than of QCM make PF-ACE the better choice for the study of heterogeneous interactions. PF-
ACE also offers great flexibility in experimental conditions and the test system. Relative to 
QCM combined with AED, two problems with PF-ACE and AED calculations are achieving 
reproducibility in the preparation of neutral capillary coatings and the poorer sensitivity. In 
summary, even though the use of AED calculations with QCM and PF-ACE requires a large 
number of concentration points and bigger sample volumes, this approach can provide an 
important extra dimension to interaction studies. 
Another important factor to be taken into consideration is the immobilization of the ligand. 
In QCM and OT-CEC the ligand is attached directly on the chip or capillary surface, which 
could result in loss of important functionalities. On the other hand, the possibility to apply 
different coating methods offers flexibility and can provide valuable information in regard to 
the functionalities actually participating in an interaction.  
QCM, PF-ACE, and OT-CEC all demonstrated potential in the study of biomolecular 
interactions. The acquisition costs of the instruments are about the same, but the consumables 
are significantly more expensive for QCM than for PF-ACE or OT-CEC. 
MST was used as a complementary technique to PF-ACE in evaluation of the strength of 
interactions between dermatan sulfate and apoE. The main advantage of MST is fast analysis 
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time and the possibility to analyze fluorescent proteins without the need for labeling. The 
consumables are more expensive than in PF-ACE.  
 
Table 15. Comparison of QCM, PF-ACE and OT-CEC in biomolecular interaction studies. 
Technique QCM PF-ACE OT-CEC 
Analysis time Moderate Fast Fast 
Sample volumes Moderate Small Small 
Acquisition costs Moderate Moderate Moderate 
Cost of consumables Moderate Cheap Cheap 
Flexibility Good Good Very good 
Possibility to combine with 
AED 
Yes Yes No 
Determination of affinity 
constants 
Yes Yes No 
Need for immobilization Yes No Yes 
Main limitations Immobilization Detection Detection, 
immobilization 
Notes Allows excellent 
sensitivity 
  
 
All analytical approaches described were successfully applied in the study of GAG–
lipoprotein interactions, and comparable affinity constants were obtained by the three 
methods (Table 16). Comparable peptide affinity constants and similar exothermic behavior 
were recorded for C6S–apoE peptide and C6S–apoB-100 peptide. QCM and PF-ACE both 
indicated stronger affinity of apoE peptide than of apoB-100 peptide for C6S. The difference 
is most likely due to the difference in the net charge (apoE peptide +7 and apoB-100 peptide 
+6), since the primary interactions are of electrostatic nature. The stronger affinity of apoB-
100 peptide for C6S found in the MD simulations suggests that the larger apoB-100 peptide 
requires longer time to interact, an effect only perhaps observable in the simulations. 
Furthermore, the MD simulations assumed helical secondary structure for both peptides, even 
though helical structure is a requirement only for the interaction between apoB-100 peptide 
and C6S. [221] In contrast, the affinity constants obtained for the C6S – apoE peptide system 
by the two experimental methods were extremely well aligned with the results of the 
molecular dynamics simulations. Furthermore, the apoE peptide exhibited the same 
heterogeneous behavior with DS that it exhibited with C6S, and the affinity constants 
obtained for DS–apoE and DS–apoE peptide interactions were in good agreement with the 
affinity constants obtained for C6S and apoE peptide (Table 16).  
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Table 16. Affinity constants (log Ka) for the primary binding site in interactions of apo 
peptides and LDL with C6S, DS, and heparin. 
 Chondroitin-6-sulfate Dermatan sulfate Heparin 
Technique QCM 
PF-
ACE 
MD QCM 
PF-
ACE 
MST QCM 
Temperature 25 °C 37 °C 37 °C 37 °C 25 °C 25 °C Ambient 25 °C 37 °C 
ApoE peptide 5.42
1
 5.31
1
 5.28 4.60 5.1
1
 - - 5.20 5.02 
ApoB-100 
peptide  
4.62
1
 4.64
1
 5.02 7.39 - - - 5.54 5.22 
ApoE2 - - - - - 6.1
1
 6.60 - - 
ApoE3 - - - - - 5.9
1
 6.61 - - 
LDL - 11.0 8.85 - - - - - - 
1
 AED 
 
Surprisingly, the affinity constant for heparin–apoB-100 peptide with charge of +6 was 
larger than that for heparin–apoE peptide with charge of +7. For both the OT-CEC and QCM 
measurements, heparin was attached to the capillary wall and chip surface via APTES, which 
reduced the number of functional groups, but especially the carboxyl groups, available for the 
interaction. The results demonstrate the importance of sulfate groups in the apoB-100 peptide 
interactions. Sulfate groups are available in both the QCM and OT-CEC methods, but 
carboxyl groups are heavily lost when heparin is immobilized on the fused silica capillary 
surface. The results clearly underline the importance of the coating procedure. 
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6. Conclusions 
The aim of this doctoral work was to develop biomimicking platforms, feasible approaches, 
and biosensing systems useful in the study of interactions between selected biomolecules. 
Four different experimental techniques with slightly different features were employed for 
elucidation of the interactions of lipoprotein and apolipoprotein particles with 
glycosoaminoglycans.  
The first two techniques investigated were quartz crystal microbalance measurements and 
open tubular capillary electrochromatography, which were used to clarify the interactions of 
lipoproteins or their nanodomains with glycosaminoglycans. These interactions are known to 
play an important role in the development of atherosclerotic plaques. Chemical modification 
of the silica chip surfaces in QCM and the fused silica capillary inner surfaces in OT-CEC 
was required for the immobilization of glycosaminoglycans in the interaction studies. The 
procedure used in QCM studies, which was both simple and fast, enabled evaluation of the 
interaction strengths as affinity constants. In OT-CEC, the interaction strengths toward the 
glycoaminoglycan employed in the stationary phase were estimated as retention factors and 
reduced mobilities.  Exceptionally, in the immobilization of heparin, the necessary 
modification of the chip and capillary surfaces with APTES led to loss of some of the 
important functionalities from the chip. In the studies with chondroitin-6-sulfate and dermatan 
sulfate, in contrast, where amine and aldehyde couplings were used in the immobilization 
step, all functionalities were left intact and available for the interactions on both surface. The 
biosensing systems for chondroitin-6-sulfate and dermatan were more reliable, therefore. 
More sophisticated methods were required to improve the usefulness of the QCM adsorption 
data and, for this purpose, AED calculations were introduced in the QCM data handling step 
to discriminate the weak and strong interactions.  
The third technique, partial filling affinity capillary electrophoresis, was employed for 
elucidation of the strong binding interactions determined in a narrow concentration range. 
These interactions were assumed to be of a single type. The PF-ACE technique enabled fast 
determination of affinity constants with no functionality losses, and the introduction of a 
novel block copolymer capillary coating made this system even easier to employ. The success 
of the combination of AED calculations with QCM prompted an examination of AED 
calculations in PF-ACE as well. Results were good when the concentration range was 
extended. As with QCM, the combination of AED calculations with PF-ACE allowed the 
heterogeneous binding to be distinguished. Even minor differences in the binding process, 
such as those between DS and two isoforms of apoE, could be distinguished. This advantage 
could easily be exploited in other biomolecular interaction studies.  
Microscale thermophoresis, still quite a new technique, was briefly tested as a fourth 
approach for GAG–lipoprotein studies. Microscale thermophoresis allows both analyte and 
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titrant to move and interact freely in a capillary without loss of important functionalities. For 
their part, whenever molecular dynamics (MD) simulation calculations were used, they 
provided excellent supportive visual insight into the interaction mechanisms. 
The affinity constants obtained for different GAG–lipoprotein systems agreed well with 
values reported in the literature. All the methods developed in this work share some important 
features. They are suitable for studies of weak interactions as well as strong, they are easy to 
carry out and, since just a small amount of material is required, they are relatively 
inexpensive. The experimental approaches developed hold great promise for studies of 
bimolecular interactions and, with minor modifications, for the investigation of a range of 
biosensing systems. 
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